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CHAPTER I 
INTRODUCTION 
Shipping fever is an entity of the Bovine Respiratory Disease 
Complex (Lillie, 1974). According to Lillie, two other major clinical 
entities of the Bovine Respiratory Disease Complex are enzootic 
pneumonia of calves and atypical interstitial pneumonia. Shipping 
fever includes several different syndromes which occur in cattle 
following shipment. The disease is characterized by mild to severe 
respiratory inflammation with a variable death loss due to pneumonia. 
It results in considerable economic loss directly (medical treatment 
and death loss) and indirectly (weight loss, poor feed utilization, and 
chronic depression of weight gains). 
Symptoms of the disease range from those nearly indetectable to 
rapidly fatal pneumonia. Hoerlein (1964) gives the following symptoms 
or signs of shipping fever: 1) Affected calves exhibit considerable 
depression, standing alone with their heads down and ears drooping; 2) 
Calves often have a gaunt appearance from almost complete anorexia; 3) 
The nasal mucous membranes may be dry or copious nasal exudate may be 
present; 4) Increased respiratory rate is often present and a 
characteristic soft cough is common in affected groups; and 5) 
Diarrhea may be present in some epizootics. 
At necropsy lesions are most prominent in the respiratory tract 
and include inflammation of the mucosa of the airways and a fibrinous 
1 
pleuritis and pneumonia with hemorrhage into the alveoli and a marked 
thickening of the interlobular septa (Collier, 1967). Varying amounts 
of the anterior and ventral portions of the lungs are affected. 
2 
Shipping fever is one of the major diseases associated with cattle 
production in the United States. Jensen et al. (1976) reported the 
results of a 1974 survey of illnesses and death in 407,000 head of 
yearling feedlot cattle. About 5.1% of the cattle became sick and of 
these, 18.9% died for a .96% death loss. Of the 3,943 fatalities, 
1,988 were necropsied and about 75% of the clinical diagnoses were 
respiratory tract diseases. Of the cattle with respiratory tract 
diseases, 75% had shipping fever pneumonia which extrapolated to a .54% 
death loss from shipping fever. Church (1980) reported the results of 
a survey of 24 feedlots in Alberta, Canada conducted in 1977 and 1978. 
A 12.9% morbidity rate and a 1.2% death loss was reported. It was 
estimated that respiratory diseases accounted for approximately 60% of 
the sickness and death loss which equaled a .72% death loss from 
respiratory disease. Herrick (1979) states that on a national basis, 1 
to 2% of all feeder cattle die during the first six weeks after they 
enter the feedlot. Losses in light 250 lb. to 350 lb calves arriving 
in Southwestern feedlots can rise to 2 to 5% (Addis, 1980a). 
The shipping fever complex is a major economic burden on the beef 
cattle industry with annual losses estimated at $200 to $400 million 
(Cole, 1982). The estimated economic losses due to shipping fever have 
increased significantly ($0.5 vs. 77 million in 1940 dollars) since 
1940 (Mohler et al., 1942; USDA, 1952; USDA, 1980). Much of this 
increase can be attributed to an increase in the number of calves 
transported long distances to feedlots as well as more intensive 
marketing and production systems. Herrick (1969) estimated that the 
disease costs $10 to $20 for every calf in the feedlot. Cope (1978) 
estimated that it costs between $12 to $15 per head for an animal to 
get sick in the feedlot. Church (1980) reported that the Canadian 
survey estimated that the total animal health cost including 
veterinarian fees, drugs and vaccines, handling costs, death losses, 
and reduced gains averaged $12.85 per head received at the feedlot. 
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Since shipping fever continues to be a major disease in cattle and 
is expensive to treat, it is important to conduct research on the 
treatment and control of this disease. The objectives of this research 
project were to evaluate the effects on the health and performance of 
newly arrived, stressed stocker calves of the following factors: 1) 
Preventative medication with long-acting oxytetracycline and sustained 
release sulfadimethoxine, 2) Coccidiostats - decoquinate and lasalocid, 
3) Recombinant leukocyte hybrid A/0 interferon, 4) Respiratory 
syncytial virus vaccine, 5) Live Pasteurella hemolytica vaccine, 6) 
Vitamin E supplementation, 7) Sequence of current and new injectable 
antibiotics and sulfas, and 8) Anthelmintics - ivermectin. 
CHAPTER II 
REVIEW OF LITERATURE 
Causes of Shipping Fever 
During the 1950's and 1960's much research was aimed at 
determining the causes of shipping fever. Hoerlein and Marsh (1957) 
proposed the following thesis for the development of the shipping fever 
complex (SFC): Stress+ Nonbacterial infection (viral)+ Bacterial 
infection = shipping fever. At least six bacterial pathogens and 11 
non-bacterial pathogens have been associated with the SFC (Hoerlein, 
1973). 
It appears that each of the three major categories (stress, 
nonbacterial infection, and bacterial infection) must provide at least 
one factor to produce the full Shipping Fever Syndrome. Hamby et al. 
(1963) studied the transmission of shipping fever in calves by 
exposing them to various infectious agents (virus and bacteria) and 
physical stress. It was observed that a single infectious agent 
alone, stress alone, or stress in combination with a single infectious 
agent failed to produce the disease. However, stress in combination 
with parainfluenza-3 and Pasteurella ssp. resulted in clinical 
signs closely resembling those seen in cattle with shipping fever. In 
additional studies, Hamby et al. (1964) reported that 
parainfluenza-3, infectious bovine rhinotracheitis, or psittacosis 
lymphogranuloma venereum virus plus Pasteurella ssp. along with 
4 
stress combined to produce shipping fever. Any of these infectious 
agents alone, stress alone,, or any other combination of infectious 
agents and stress failed to produce the disease. Similar results were 
obtained in a study by Trapp et al. (1966). 
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Carter (1973) proposed the following thesis for the development of 
shipping fever. Collier (1968b) put forward essentially the same 
thesis. 
1) The upper respiratory tract of cattle frequently harbors a 
considerable number of potentially pathogenic organisms. Different 
individuals and herds may harbor different organisms. 
2) The bringing of cattle together from different sources results 
in an exchange of these organisms. 
3) Mild and clinically inapparent viral infections occur 
continually in cattle. When cattle from different sources are brought 
together these infections become more frequent and severe. Mycoplasmas 
also might cause respiratory infections. 
4) As a result of various environmental stresses, these mild 
infections are aggravated, with resulting dissemination of infectious 
agents by droplet infection and fomites. Stresses lower resistance to 
infectious agents. Viral pathogens are capable of destroying the 
11mucus escalator 11 of the respiratory tract by infecting the ciliated 
and mucus secreting cells (Hoorn and Tyrrell, 1966). 
5) The damaged respiratory tract offers very favorable conditions 
for secondary invaders, bacteria such as P. multocida and P. 
hemolytica. 
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Viruses 
During the 1960 1 S much research was conducted looking at the 
relationship of parainfluenza-3 (PI-3) virus with shipping fever. It 
was first isolated from calves with clinical signs of SFC by Reisinger 
et al. (1959). Other isolations were subsequently reported by Hoerl ein 
et al. (1959), Gale and King (1961), Bryne et al. (1961), and Sweat 
(1967). Brown (1979) and Wilkie (1980) suggest that PI-3 can be 
disregarded as a significant primary bovine pathogen. Brown (1979) 
reported that PI-3 is seldom found as a cause of generalized infection 
in High Plains feed yards. Its presence is not characterized by overt 
lesions, and where illness occurs and lesions are found, lesions are 
attributable to other more virulent micro-organisms. PI-3 is a very 
common cause of infection but is seldom a cause of clinically apparent 
respiratory disease (Brown, 1979). 
There is also an abundance of research concerning infectious 
bovine rhinotracheitis (IBR) and its relationship with shipping fever. 
This virus was isolated from cattle with shipping fever in California 
(Madin et al., 1956) and in Maryland (Reisinger et al., 1959). More 
recently Jensen et al. (1976) and Brown (1979) have reported that IBR 
is associated with SFC in feedlot cattle. Brown (1979) reported that 
the virus appears to be of lessening significance as a primary viral 
pathogen in bovine respiratory disease in High Plains feed yards. It 
is suggested that this is a result of the standard practice of 
relatively effective IBR vaccination of both breeding animals and 
feeder calves. 
Bovine virus diarrhea (BVD) virus is another important infectious 
agent associated with shipping fever. Studies by Reggiardo (1979) and 
Martinet al. (1980) showed that it plays a role in SFC. Brown (1979) 
reported that BVD virus is the infectious agent most frequently 
isolated from bovine respiratory disease outbreaks in High Plains feed 
yards characterized by unusually high morbidity and mortality. It is 
suggested that clinical shipping fever, non-responsive to antibiotic 
medication, is the condition that the veterinarian should learn to 
recognize and associate with bovine virus diarrhea infection. 
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Rosenquist (1983) reported on several "less well-recognized" 
viruses that are associated with bovine respiratory disease. These 
viruses include "Type 4" bovine herpes viruses, adenoviruses, 
respiratory syncytial virus, reoviruses, rhinoviruses, and 
enteroviruses. The most widespread of these other viruses is 
respiratory syncytial virus (RSV). Rosenquist (1983) reported that 
where testing for RSV has been done in the United States, the number of 
seropositive cattle ranges from 38 to 100 percent. It is reported that 
approximately 88 percent of Missouri beef and diary calves less than 
one year of age are seropositive. The virus has been detected in 
respiratory infections of cattle with severe clinical and pathological 
features (Rosenquist, 1974) and recent work has suggested that it may 
be associated with the Acute Respiratory Distress Syndrome of calves 
(Frey, 1983). 
Bacteria 
Several review articles address the subject of bacteria in SFC 
(Collier, 1968a, 1968b; Carter, 1973; Lillie, 1974). The clinical 
signs of SFC are largely caused by bacterial components since treatment 
with antibiotics and sulfonamides generally provide dramatic results 
(Hoerlein, 1973). Pasteurella multocida was known to be associated 
with SFC several years before the importance of Pasteurella 
hemolytica was discovered (Farley, 1932). During the 1950's and 
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early 1960's P. hemolytica was isolated from calves with SFC (Carter, 
1954; Gale and King, 1961; Hoerlein et al., 1961; Collier et al., 
1962). More recently, P. hemolytica and less frequently, P. multocida, 
have been isolated from the pneumonic lungs of feedlot cattle (Jensen 
et al., 1976; Hjerpe and Routen, 1976; Reggiardo, 1979; Martinet al., 
1980). P. hemolytica Type I is the most commonly isolated bacterial 
pathogen from the acutely affected bovine lung (Brown, 1979; Frank and 
Smith, 1983). 
Corynebacterium pyogenes has been isolated from pneumonic 
lungs as well as from healthy tissues from the upper respiratory tract 
(Hjerpe and Routen, 1976; Brown, 1979; Frank, 1983). It is a known 
pathogen often found in abscesses of cattle, swine, sheep and goats, 
but its involvement in bovine respiratory disease is unknown (Frank, 
1983). 
Haemophilus somnus has been isolated from cattle with 
bronchopneumonia and fibrinous pneumonia. Its involvement in typical 
bovine respiratory disease is unclear (Brown, 1979; Stephens et al., 
1981). 
Mycoplasmas are isolated with great frequency from cattle with 
bovine respiratory disease (Hjerpe and Routen, 1976; Jensen et al., 
1976). They are isolated both from pneumonic lungs and from the 
respiratory tracts of healthy calves, but their role in bovine 
respiratory disease has not been determined (Stalheim, 1983). 
Stress 
Brown (1959) defined stress as a harmful condition resulting from 
the inability of the organism to maintain an adequate internal 
environment. Wilson (1971) defined stress as the load on the animal 
system and the resulting strain of that load is the physiological 
response. The magnitude of the stress will dictate the amplitude of 
the response by the organism if it can respond. Phillips (1982) 
divided the types of stress imposed on beef cattle into five major 
areas: physical, nutritional, physiological, environmental, and 
productive. Since mature cattle are not confronted with as many new 
and different situations as immature cattle, they are subject to fewer 
kinds of stress than calves. To the calf, all experiences are new and 
most are perceived as stressful. The inability to respond or to 
maintain the response to stress lowers the resistance of the calf to 
viral and bacterial agents and can result in SFC. 
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Physical stress includes such factors as restraint, dehorning, 
castration, identification, transportation, and assembly. Martin et 
al. (1980) reported that there was a lower death loss among cattle not 
having to be dehorned in Canadian feedlots. Addis et al (1980b) 
reported that castration of newly received calves decreased daily gains 
by 26%, feed intake by 12%, and feed efficiency by 22%. Davis (1978) 
reported that dehorning, castration, or a combination of both resulted 
in lowered daily gains and increased morbidity and mortality in 
stressed calves. Castration with a burdizzo tended to decrease gains 
and increased death loss more than surgical castration. Zinn et al. 
(1985a) noted that dehorning of newly arrived feedlot calves did not 
" 
, . 
. 1 
10 
influence animal health or performance, whereas castration reduced 
weight gains (P<. 05). Zwei acher et al. (1979) reported that castration 
by emasculation tended to decrease gains and increase sickness more 
than castration by elastrator-ligation. 
One of the major factors affecting the performance and health of 
stocker calves is the farm of origin. Mclaren et al. (1978) reported 
that the farm of origin was a significant factor in weight gain and 
loss during assembly, transportation, and after arrival at the feedlot. 
Farm of origin explained 9.4 to 26.9% of the variation in weight 
changes and 7.3 to 56.4% of the variation in rectal temperature at 
various points from farm to feedlot. The amount of variation explained 
by farm of origin was less at each assembly site (auction, barn, order 
buyer barn, transportation, and feedlot). Feedlot morbidity was 
significantly affected by farm of origin and varied from 15 to 90% 
across farms. Phillips and Leining (1981) noted that transit of 
yearling steers resulted in elevated rectal temperatures. Camp et al. 
(1981) reported significant differences in weight gains and morbidity 
due to differences in shipping dates. Camp et al. (1983) observed a 
high positive correlation between market-transit weight loss (shrink) 
and subsequent incidence of bovine respiratory disease. Apparently the 
incidence of shipping fever is effected by time in transit and 
environmental conditions before, during, and immediately after transit. 
Griffin (1983) speculated that 25% of the problems in receiving cattle 
at Oklahoma Panhandle feedlots can be attributed to shrink involved in 
animal transport and another 25% of the problems can be associated with 
either the order buyer or geographical origin of the calves. 
Nutritional stresses include dietary changes, feed deprivation, 
water deprivation, irregular feeding, protein deficiency, and mineral 
imbalance. Nutrition-health interactions will be discussed later in 
this review. 
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Psychological stresses include weaning, change in location, change 
in social order, transit, feeding pattern, and space allowance. 
Weaning is one of the more severe stresses of feeder calves (Wieringa 
et al., 1974, 1976). Martinet al. (1982) in a survey of Canadian 
feedlots, observed that mixing of cattle after arrival was consistently 
associated with increased mortality and health cost. It is suggested 
that this is most likely due to the introduction of larger numbers 
and/or new strains of respiratory pathogens. However, the stress 
involved with the change could also play an important role. 
Environmental stresses include heat, cold, winds, humidity, solar 
intensity, and day-light. Young (1981) summarized feedlot performance 
of beef calves at different geographic locations and during different 
seasons. The locations varied from the northern climate of Canada to 
the warmer southern climate of the Texas Panhandle. Only small 
differences were noted in daily gains, but feed efficiency was lower at 
colder locations and within each location seasonal variations in 
gains were noted. Schake et al. (1971) in summarizing the performance 
of 150,000 West Texas calves noted seasonal variations for daily gain 
and mortality. 
Productive stresses include conception, gestation, parturition, 
lactation, and growth. These stressors are primarily associated with 
mature beef cows and not feeder calves. 
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Vaccines 
Much research has been conducted over the past 25 years with 
parainfluenza-3 (PI-3), infectious bovine rhinotracheitis (!BR), and 
bovine virus diarrhea (BVD) virus vaccines. Most feedlots now 
routinely vaccinate for PI-3 and IBR viruses. These vaccines, though 
useful, will not prevent SFC because of the large number of infectious 
agents and stressors involved in the development of the disease. 
Martin (1983) in a review of laboratory experiments and field trials 
conducted to determine the efficacy of vaccination reported that there 
was little published data to support the use of virus vaccines (PI-3, 
IBR, IBR/PI-3, and BVD) against respiratory diseases under feedlot 
conditions. 
Over the past 50 years much research has been conducted with 
Pasteurella bacterins in an effort to control SFC. Wilkie (1980) 
reviewed studies on the biological control of SFC and concluded that 
Pasteurella bacterins do not have obvious usefulness in control of the 
disease. Farley (1932) reported that vaccination of 5,661 cattle with 
Pasteurella bacterins was associated with a death loss of 3.58% 
compared with 1.02% for 4,119 nonvaccinated controls. Similarly, more 
recent field trials have indicated that vaccinated calves had higher 
morbidity, higher mortality, and reduced weight gains when compared to 
nonvaccinated calves (Hamby et al., 1965; Woods et al., 1976; Amstutz 
et al., 1981). Martin et al. (1980) observed higher mortality in 
calves vaccinated at the time of arrival in Canadian feedlots with 
viral (PI-3, IBR, and BVD) and bacterial agents. 
Recent research with live Pasteurella hemolytica vaccine has 
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shown more promising results. Hutcheson et al. (1983) reported the 
results of a study with 93 calves in which approximately one-half of 
the calves were vaccinated with experimental live P. hemolytica 
intradermal vaccine and the other half served as controls. No 
significant differences in morbidity, mortality, or performance of the 
two groups was seen. However, the geometric mean antibody titer to P. 
hemolytica was statistically greater in vaccinates than controls 14 
days after vaccination. Purdy et al. (1983) vaccinated 41 calves (51 
control calves) with modified live P. hemolytica. The vaccine had no 
significant effect on average daily gains or morbidity, but both 
morbidity and mortality were slightly decreased by vaccination. 
Smith (1983) reported the results of field tests in which a live 
P. hemolytica vaccine (PRECON-PH) was tested. In field tests of 
commercial cattle comparing 225 vaccinated calves with 1,225 
nonvaccinated calves, morbidity and mortality were reduced by 
vaccination. The incidence of bovine respiratory disease among the 
nonvaccinated calves was 17.4% with 2.3% mortality while the incidence 
among co-mingled vaccinated calves was 2% with no mortality. In field 
trials in which the vaccine was used with a preconditioning program, 
the incidence of BRD was 55.2% among the non-preconditioned calves and 
12.7% among the preconditioned calves. In a feedlot trial, the vaccine 
was used to vaccinate feeder calves upon arrival. The incidence of BRD 
among the co-mingled vaccinated calves was reduced 44% as compared to 
the nonvaccinated cattle and the number of treatments per case was 
reduced by 40%. 
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Interferon 
Interferon is a small protein which is produced or released by 
animal cells in response to invasion by viral or certain nonviral 
stimuli and which indirectly protects other cell.s against viral damage 
by stimulating the production of new antiviral polypeptide or protein 
(Rosenquist, 1973). It is believed to have an important role in the 
recovery of host animals from viral infections (Isaacs, 1963; Baron et 
al., 1966). Baron (1970) pointed out that interferon is an important 
part of the body•s non-immune defenses and is probably the major 
cause of recovery from already established viral infections. Interferon 
appears early in infection, in contrast to circulating antibody, and is 
present before lesions occur. It can intracellularly inhibit the 
multiplication of viruses in animal tissues. Thus, it seems to provide 
a mechanism for the recovery of animals from viral infections and is 
independent of the specific immune mechanisms (Rosenquist and Loan, 
1969). 
Rosenquist (1973) noted that viruses of almost every major viral 
group have been shown to induce and be affected by interferon though 
some are more efficient stimulators of interferon production or are 
more sensitive to its actions than others. Those viruses most commonly 
associated with SFC that have been shown to induce interferon 
production are PI-3 (Rosenquist and Loan, 1967; Trueblood and Manjara, 
1972) and IBR (Rosenquist and Loan, 1969; Todd et al., 1972; Cummins 
and Rosenquist, 1980, 1982a, 1982b). Interferon has been shown to 
protect against heterologous respiratory tract viral infections (Todd 
et al., 1972; Cummins and Rosenquist, 1980, 1982a, 1982b). Fulton and 
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Cummins (1983) noted that IBR virus is sensitive to the antiviral 
effects of bovine and human_ alpha interferon in vitro. Cummins and 
Hutcheson (1982) tested the hypothesis that interferon induced by an 
intranasal IBR/PI-3 vaccination would protect feedlot calves against 
natural viral challenge during a shipping fever outbreak. In this 
experiment, the attempt to enhance interferon production by vaccination 
was not beneficial. More morbidity and mortality were observed in the 
vaccinated calves than the controls, though this difference was not 
significant. 
Cummins and Hutcheson (1983) conducted a study to determine the 
efficacy of human leukocyte interferon in calves infected with IBR 
virus. Twenty-eight head of 36 virus infected calves were given 
interferon once daily on the day of, and for two days subsequent, to 
virus inoculation by three different routes (intravenously, orally, and 
intranasally) at three different dosage concentrations. Calves given 
interferon intravenously performed the poorest (30% death loss) and 
calves given interferon orally at the lowest dosage out-gained all 
other groups. 
Preventative Medication 
A high incidence of sickness due to SFC is only a problem during 
the first month for calves received at feedlots. It is important that 
an effective animal health program be used the moment a shipment of 
calves arrives at a feedlot. The cattle must be started correctly if 
they are to be profitable. Compared with sick cattle, cattle that 
remain healthy should consume more feed, gain faster, and require fewer 
dollars in medication and feed costs. One approach to prevent 
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excessive death loss and decreased performance of newly received 
stocker cattle is to mass medicate all animals on arrival with 
antibiotics. This approach is based on the premise that most of the 
cattle will get sick shortly after arrival and that sickness is not 
easily identified on arrival. The primary considerations in mass 
medication are (1) effectiveness and (2) economics. Cost is justified 
only if most of the calves get sick shortly after arrival. 
Schipper and Kelling (1974) reported the results of a study in 
which 1167 calves in five feedlots were given a subcutaneous injection 
of procaine penicillin G and benzathine penicillin G with or without 
dihydrostreptomycin sulfate (Longicil-F or Longicil-S) or 
dihydrostreptomycin alone. All three of the preventive medication 
treatments significantly reduced morbidity as compared to the controls, 
though no significant difference was observed between preventive 
treatments. The combination of the two penicillins without 
dihydrostreptomycin was most effective in preventing SFC in calves 
during their first 14 days in the feedlot. 
Addis et al. (1976) reported the results of three 28-day trials in 
which the intramuscular (IM) administration of oxytetracycline for the 
first three days after arrival of stressed calves in the feedlot (10 
cc/100 lbs body weight) was compared to the oral administration of 
oxytetracycline at the rate of 1 gram per head per day in the feed plus 
1 gram per head per day in the water until the animals were consuming 
2% of their body weight in feed. · It was observed that the 
intramuscular injection of oxytetracycline reduced morbidity by 43% and 
30% as compared to the controls in two trials. The oral administration 
of oxytetracycline reduced morbidity by 48% in one trial but showed no 
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effect on sickness in the other two trials. The number of medical 
treatments per sick animals was reduced an average of 10% by the IM 
administration of oxytetracycline (3.7 versus 4.1). The percent of 
treated cattle requiring re-treatment (returns or repulls) was 
decreased by IM oxytetracycline in all three trials and oral 
administration in two trials. Though no significant difference in 
weight gains were observed in the three trials, IM oxytetracycline 
tended to slightly improve gains and both oxytetracycline treatments 
tended to improve efficiency of feed use. Oral oxytetracycline tended 
to decrease feed intake. But the total cost per pound of gain over the 
28 day receiving period was increased by preventive medication in all 
three trials. 
Lofgreen (1978) and Lofgreen et al. (1980) reported the results of 
a study with 514 stocker calves in which one-half of the calves 
received intramuscular oxytetracycline (11 mg/kg body weight) for the 
first three days after arrival. Mass medication significantly reduced 
the death loss, morbidity, and returns by 46%, 35%, and 75%, 
respectively. However, calves in need of further medication after 
three days of oxytetracycline treatment were sick two days longer than 
calves requiring treatment from the control group. Daily weight gains 
and feed efficiency were improved by 29% and 23% (P<.05), respectively, 
by preventive medication. The total medication cost per calf was 
increased by mass medication, but due to the improved gain and feed 
efficiency, the total cost per pound of gain over the 28 day trial was 
decreased by mass medication. This contrasts with the study by Addis 
et a l. ( 19 7 6) • 
Lofgreen (1983) reported the results of a study with 353 stocker 
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calves comparing three treatments: control (receiving no preventive 
medication), three successive days of intramuscular oxytetracycline (11 
mg/kg body weight) beginning on the arrival date, or the oral 
administration of sustained release sulfadimethoxine (150 mg/kg body 
weight) in bolus form. Both of the preventive medication treatments 
reduced morbidity by approximately 14% and significantly reduced the 
number of treatment days per calf purchased (21%). The 
sulfadimethoxine treatment did not affect weight gains or feed 
efficiency. Whereas, the oxytetracycline treatment increased daily 
feed intake, daily weight gain, and feed efficiency by 4%, 12%, and 8%, 
respectively, over the 28 day trial. 
The results of a similar study with 263 heifer calves were 
reported by Lofgreen (1982, 1983). The same preventative treatments 
were compared with the addition of a fourth treatment which was three 
days of oxytetracycline treatment with sustained release 
sulfadimethoxine administered at the time of the third oxytetracycline 
injection. Morbidity and the number of treatment days per calf 
purchased were reduced by 17% and 31%, 44% and 54%, and 77% and 81% by 
oxytetracycline treatment, sulfadimethoxine treatment, and the 
combination treatment, respectively. None of the mass medication 
procedures affected feed intake or weight gains during the 28 day test. 
Lofgreen (1983) observed in another experiment that the combination 
treatment of three successive days of oxytetracycline treatment 
followed by sustained released sulfadimethoxine reduced morbidity and 
treatment days per calf purchased by 77% and 85%, respectively. An 
additional preventive treatment was studied in this experiment which 
was the combination of oxytetracycline and sulfadimethoxine followed by 
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feeding 700 mg of chlortetracycline plus 700 mg of sulfamethazine per 
head per day for one week. Providing feed medication during the second 
week did not improve performance beyond that achieved with the 
oxytetracycline followed by sulfadimethoxine. 
Janzen and McManus (1980) reported the results of a study in a 
Canadian feedlot with a long-acting oxytetracycline used in 
preventative medication. This product eliminates the necessity of 
rehandling calves to administer successive doses following processing. 
In this study, all cattle were processed upon arrival and treated for 
shipping fever if rectal temperature exceeded 104°F. When the 
incidence of SFC in a pen reached 6 to 10%, the animals in that pen 
were alternately treated with long-acting oxytetracycline (20 mg/kg 
body weight) or a control placebo. The long-acting oxytetracycline 
reduced morbidity by 78% and improved daily gains by 13%. 
Davis and Caley (1981) conducted a study comparing a long-acting 
IM oxytetracycline administered at two levels (5.3 mg and 8.0 mg/lb 
body weight). Also the typical processing procedure (calves with 
temperatures above 103°F were given intramuscular injection of 
oxytetracycline during processing) was compared with preventative 
medication (each calf given an intramuscular injection of 
oxytetracycline during processing). Both levels of long-acting 
oxytetracycline given as preventative medication tended to increase 
rate of gain and feed intake and reduce the times sick calves were 
treated and the number of deaths (2% vs 12% mortality) as compared to 
calves receiving oxytetracycline only if their temperature was above 
103°F. The lower level of oxytetracycline given as preventative 
medication significantly improved weight gains as compared to the same 
level given only to calves with elevated temperatures. Performance 
tended to be highest in calves receiving the lower level of 
oxytetracycline as preventative medication. 
Swafford et al. (1983) investigated the use of long-acting IM 
oxytetracycline (18 mg/lb body weight) as preventive medication. 
Preventative medication reduced mortality by 50%, decreased morbidity 
by 15%, and improved daily gains by 17%. 
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Gill and Richey (1982) summarized a study using long-acting 
oxytetracycline plus sustained release sulfadimethoxine as preventative 
medication administered at the time of arrival of 163 newly received 
stocker cattle. Mass medication decreased morbidity by 21% as compared 
to those calves not receiving medication at processing. However, it 
was observed that mass medication caused a greater number of calves to 
become sick during the second week and returns increased from 20 to 
31%. 
Lofgreen (1983) in a similar investigation with 244 head of feeder 
calves compared the injection of long-acting oxytetracycline (20 mg/kg 
body weight) at arrival plus oral administration of sustained release 
sulfadimethoxine (150 mg/kg body weight) at arrival or on day three. 
Control calves received no preventative medication. Mass medication 
with oxytetracycline, followed by sulfadimethoxine on day three, 
reduced morbidity and treatment days per calf purchased, by 90% and 93% 
(P<.05), respectively. Very similar results were observed with both 
drugs administered at processing (89% reduction in both morbidity and 
treatment days per calf purchased). Both mass medication treatments 
improved weight gains by approximately 27% and feed efficiency by 
approximately 16%. The total cost per pound of gain was reduced by 
preventive medication. 
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Lofgreen et al. (1984b) investigated the effects of preventative 
medication of feeder calves with long-acting oxytetracycline and 
sustained release sulfadimethoxine at arrival versus preventative 
medication on day eight after arrival. These long acting drugs 
supposedly do not maintain adequate drug levels past four days. Even 
though symptoms of SFC were not observed until five days after arrival, 
medication on day one reduced both morbidity and treatment days per 
calf purchased by 93%. In the group receiving mass medication on day 
eight, no new calves were pulled for SFC treatment after day seven. 
Only a 24% reduction in morbidity was reported in the day eight 
medicated calves since the majority of the sick pulls occurred on days 
five through seven. However, day eight medication reduced treatment 
days per calf purchased by 61%. In contrast to the previous studies, 
mass medication in this study did not improve weight gains or feed 
conversion. 
These data indicate that administering long-acting oxytetracycline 
plus sustained release sulfadimethoxine at processing will improve 
weight gains and reduce morbidity in newly received calves. Giving 
only long-acting oxytetracycline also increases gains and reduces 
morbidity but to a lesser degree than a combination of the two drugs. 
The economics of mass-medicating cattle depends on the cost and success 
of conventional treatment (treatment of sick calves only), availability 
of labor, ability to detect sick cattle early, and on the health status 
of received cattle. If mass medication procedures are to be used, 
their cost must be offset by savings in labor, treatment medication, or 
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improved animal performance. Mass medication should be most economical 
in cattle experiencing high morbidity. 
Time of Processing 
Knight et al. (1972) compared the performance of feeder calves 
vaccinated three weeks before weaning, at weaning, or upon arrival at 
the feedlot. Those calves vaccinated three weeks prior to weaning had 
lower morbidity and mortality rates and gained weight faster than the 
other two groups. Results of this study suggested that vaccination 
three weeks before weaning is efficacious. In contrast, Greathouse et 
al. (1968) and Coleman (1973) observed no performance difference 
between feeder calves vaccinated two weeks before shipment or upon 
arrival. Sweat (1968) suggested that the optimum time to vaccinate 
would be three to four weeks before weaning. Hoerlein (1973) 
recommended vaccination at least three weeks before shipment. 
Calves moving into feedlots come from many sources and usually 
pass through several sale barns or assembly points before they reach 
their final destination. Hence, it is difficult to establish a program 
to uniformly vaccinate or precondition calves three to four weeks 
before shipment. Also, vaccination does not benefit the seller so the 
seller must be compensated by the buyer for the the expense of 
vaccination. Though possible and justified, such compensation is 
seldom provided. 
Lofgreen et al. (1978) used 358 calves to study the effects of 
processing (branding, castrating, deworming, and vaccinating) at the 
point of origin immediately prior to shipping, immediately upon arrival 
at the final destination, or two to three weeks after arrival at the 
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feedlot. Delayed processing increased morbidity and mortality and 
increased the number of repulls. Although processing at origin or on 
arrival did not increase morbidity, it did increase the proportion of 
calves requiring earlier treatment. Delayed processing delayed the 
onset of sickness in some calves. Delayed processed calves had 
significantly lower feed intakes, weight gains, and feed efficiencies 
over the four week receiving period despite the fact that they had 
higher daily gains and a more efficient feed conversion during the 
first week after arrival •. Hence, delaying processing for two to three 
weeks allowed the calves to recover faster from the stresses of 
marketing and shipping but the stress of processing later depressed 
performance more than processing eithar at the farm of origin or on 
arrival. The differences persisted throughout an entire feeding period 
of 342 days, although time of processing had no effect upon performance 
during the post-receiving period. 
Similar results were reported by Zinn et al. (1985b) in which 
calves processed at arrival gained 9% faster and 5% more efficiently 
over a 42 day receiving period than calves processed two weeks after 
arrival. Delayed processed calves· gained 18% faster than calves 
processed at arrival during the first two weeks but gained 60% less 
than calves process.ed at arrival during the second two-week period. 
Lofgreen et al. (1984a) reported the results of a study with 324 
newly received calves comparing processing on days one, three, six, or 
12 following arrival. The gains of calves processed on day three never 
dropped below the gains of day one calves, indicating no detrimental 
effect of delaying processing until the third day following arrival. 
The gain of calves processed on day six dropped slightly below the gain 
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of calves processed on day one but these calves recovered by 42 days on 
feed. But calves processed. on day 12 had consistently lower weight 
gains and feed efficiencies over 42 days. Although calves processed on 
days six and 12 appeared to be stressed more than those processed 
earlier, they compensated for this stress by the end of the full 238 
day feeding trial. Very little sickness and no death loss were 
reported in this study. In the case of calves experiencing high 
morbidity during the early phase of receiving, the additional stress of 
processing on days six and 12 may prove to be more detrimental than 
observed in this trial. 
These data indicate that newly arrived calves processed at arrival 
experience fewer health problems and gain faster than calves processed 
one to two weeks after arrival. If added stress will increase 
mortality, delayed processing could be useful, but unless extreme, 
intensity may be less important economically than duration of the 
stress. 
Treatment of Shipping Fever 
Detection of Sickness 
One common method to detect sickness in newly received calves is 
by rectal temperature. Normally cattle permit their temperature to 
fluctuate rather than expend energy to hold it constant. Temperatures 
of normal cattle can range from 100°F to 108°F and follow a diurnal 
pattern. The magnitude of the fluctuation is affected by environmental 
temperatures and the adaptation of the animals. Gill and Richey (1982) 
observed that movement or excitement of cattle will raise normal body 
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temperature. Lofgreen (1979) reported that the mean temperature of 
newly received calves increased 1.5°F during a four hour processing 
period while a temperature increase of 1°F during a five hour 
processing period was reported by Axe et al. (1984). The probability 
that a newly received calf will be treated for sickness at a later date 
increases as processing temperatures increase (Lofgreen et al., 1973; 
Dunbar et al., 1980; Axe et al., 1984). 
When normal body temperatures are at the diurnal low point and are 
not elevated by the stresses of movement, animals with elevated 
temperatures due to infection may be separated from healthy cattle 
based on temperature (Gill and Richey, 1982). To detect sickness based 
on temperature, newly received cattle should be rested over night 
before processing, calves should be processed in small groups early in 
the morning before outside temperatures rise, no calf should be out of 
its pen for over 30 minutes, and extra care should be exercised to 
process the cattle with a minimum of stress. Under such conditions, 
Gill and Richey (1982) reported that calves with rectal temperatures of 
a 104°F or greater can be designated as sick. Other workers have also 
used 104°F as the break point between healthy and sick calves (Dunbar 
et al. 1980; Janzen and McManus, 1980; Axe et al., 1984). While 
Lofgreen et al. (1975) used 103°F to detect sickness in receiving 
calves. Lofgreen et al. (1981) has also used a sliding break point. 
At the start of processing, each calf with a rectal temperature of 
103°F was considered to be sick but this was increased by .2°F every 
15 minutes during processing. 
Use of Antibiotics 
Fales et al. (1982) performed susceptibility tests to 15 
antimicrobial agents on isolates of Pasteurella ssp. recovered from 
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386 beef cattle with bovine respiratory disease. From the data 
collected, they recommended that the first drug choices for treating 
bovine respiratory disease should be erythromycin and 
sulfachlorpyridazine with tetracycline as an alternate drug. Hjerpe 
and Routen (1976) also measured the antimicrobial sensitivity of 
Pasteurella isolated from nasal secretions of cattle with feedlot 
pneumonia and determined the following sensitivities: tetracycline- 63 
to 97%, erythromycin - 22 to 35%, sulfamethazine - 82%, and ampicillin 
- 83%. In contrast, Amstutz et al. (1982) reported that 90% of P. 
Hemolytica strains recovered from calves with bovine respiratory 
disease complex were resistant to streptomycin and tetracyclines, 24% 
were resistant to sulfonamides, and 41% were resistant to ampicillin. 
Breeze and Magonigle (1979) and Breeze et al. (1980) stressed 
Holstein steer calves by wetting them alternately with hot and cold 
water four times and infecting them with P. multocida. The following 
treatments were initiated two hours after infection: no medical 
treatment, oxytetracycline given at 5 milligrams per pound of body 
weight twice at daily intervals, or long-acting oxytetracycline given 
once at 9 milligrams per pound of body weight. In both studies, the 
overall response to both drugs was essentially equal but the 
long-acting formulation reduced labor, handling, and stress in 
pneumonic calves. 
Nash (1983) examined the response of 212 sick feedlot calves to 
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the following treatments: long-acting oxytetracycline (15 to 19 mg/lb 
body weight) plus 2 sustained-release sulfadimethazine (SRS) boluses, 
2,500 milligrams of oxytetracycline IV for three days plus two SRS 
boluses, or 2,000 milligrams of both oxytetracycline and tylosin IV for 
three days plus two SRS boluses. No response differences were observed 
between the three treatment groups, but the use of long-acting 
oxytetracycline reduced the handling of the calves since they were 
treated only once rather than on three successive days. 
The efficacy of long-acting oxytetracycline for single-day 
treatment of bovine respiratory disease was evaluated at levels of 10, 
15, and 20 milligrams per pound of body weight in morbid feedlot cattle 
as compared to a four-day treatment sequence of oxytetracycline (5 
mg/lb body weight) by Bennett and Rupp (1983). All treatments were 
administered with an initial dose of sustained-released oral 
sulfadimethoxine. Duration of treatment favored the 15 milligram per 
pound long-acting oxytetracycline plus sulfadimethoxine. Cattle 
administered the oxytetracycline on four consecutive days had 
considerably higher treatment relapse rates and much higher labor 
costs. Results by Edwards (1983) also favored long-acting 
oxytetracycline over a three-day sequence of antibiotics. 
Nutrition and Health 
Recent studies have shown that nutrition can have a significant 
effect on the incidence of SFC in stressed calves. Williams and 
Mahoney (1984) in a review of nutrition-health interactions observed 
that under-nutrition predisposes animals to disease and increases 
disease severity and mortality. This is presumably due to altered 
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intra- and extra-cellular biochemical environments which influence the 
immune response. Globulins, lysozyrnes, interferons, and other 
substances involved in the immune response are synthesized from amino 
acids, vitamins, and minerals. Hence, a nutritional deficiency of 
these nutrients could reduce immunological competency, reduce the 
immune response, and increase susceptibility to disease. Fasting as 
well as malnutrition can reduce immune response and both reduce 
resistance to bacterial diseases more than to viral diseases. 
Stress and Rumen Environment 
Many of the nutrients fed to ruminants never reach the tissues due 
to fermentation by microorganisms in the rumen. Instead they are 
converted into other compounds prior to absorption. The rumen of a 
healthy calf contains billions of bacteria and protozoa. The stresses 
of weaning, handling, and shipping tend to cause calves to reduce their 
feed intake. This in turn can reduce the number of bacteria and 
protozoa in the rumen and alter or decrease the nutrient supplies 
absorbed (Williams and Mahoney, 1984). 
Baldwin (1967) studied changes in the rumen after a 48 hour 
starvation period and noted the following: 1) Nearly complete absence 
of rumen protozoa, 2) Rumen bacteria numbers were reduced by 75 to 90% 
of normal, 3) The surviving bacteria types were markedly reduced, and 
4) Total ruminal fermentation activity and capacity was reduced by 85 
to 90% of normal. Research by Hamlett et al. (1982) supports these 
findings. They reported that after weaning calves had been fasted for 
24 hours at a auction barn rumen liquid volume decreased by 26%, gas 
producing potential decreased by 71%, volatile fatty acid concentration 
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decreased by 25%, and rumen protozoal concentration decreased by 50%. 
Since these changes that occur in the rumen are rapid, it is 
important to reduce stress and feed calves properly to increase their 
immune response and disease resistance. Nutrient modifications before, 
during, and after stress have been tested. 
Feeding Before Stress 
Creep feeding should improve the nutrient status of calves prior 
to stress but little data on the effect of creep feeding on the feedlot 
performance and health of stressed calves is available. Pate and 
Crockett (1974) looked at the effects of creep-feeding calves 24 days 
before shipping them directly from a Florida ranch to a Texas feedlot 
at weaning. Creep-fed calves had 42% less weight loss during transit, 
13% faster daily feedlot gains, 3% better feed conversion, and 24% less 
sickness than calves that were not creep fed. In contrast, Stuedemann 
et al. (1966) reported that creep feeding calves during a 240 day 
pre-weaning period reduced subsequent feedlot performance. 
Feeding During Stress 
Feeding during stress includes the post weaning feeding of calves 
at the farm of origin as well as the feeding of calves through the 
marketing channels (Cole, 1982). Cole et al. (1978, 1979, 1982) 
examined the effect of a 30 day post weaning feeding period at the farm 
of origin on feedlot performance and health of calves. The post 
weaning feeding of the calves did not affect feedlot gains, but did 
increase feed intake which resulted in less efficient feedlot gains. 
Though the incidence of SFC was reduced, adverse effects on feed 
efficiency offset this benefit. 
Cole et al. (1978, 1979) and Hutcheson et al. (1984) fed 
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newly weaned calves either an oxytetracycline fortified, 50% 
concentrate diet or hay for three days at the order buyer barn. Diet 
had no affect on feedlot gains or feed efficiency, but morbidity and 
mortality were reduced with the concentrate diet. Feeding a 55 to 60% 
concentrate ration (oxytetracycline fortified) three days prior to 
shipment also increased weight gains and reduced morbidity and 
mortality during a 28 day receiving period (Koers et al., 1975a). Cole 
and Hutcheson (1985) suggested that before a feed and water deprivation 
period such as marketing and transport, feeder calves should be allowed 
free choice access to feed and water in order to reduce the amount of 
time required to restore normal feed intake after arrival at the 
feedlot. 
Feeding After Stress 
The diet fed upon arrival at the feedlot also can alter calf 
health and performance. Hutcheson (1980) reported that the feed intake 
of newly received calves is subnormal for the first two weeks after 
arrival at the feedlot and not all calves eat during the first week. 
Thus, it is important that rations be formulated to be as palatable as 
possible and fortified to provide enough nutrients for calves eating 
small amounts of feed. For discussion, this research is divided into 
sections on protein level and source, concentrate level and source, 
roughage level and source, mineral levels, vitamin levels, and 
miscellaneous feed additives (coccidiostats and ionophores). 
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Protein Level. The protein requirement of newly received calves 
remains undecided. Cole and Hutcheson (1982) reported a small increase 
in daily gain (0.22 lbs) and reduction in mortality (15% vs. 8%) when 
the protein level of the ration was increased from 12 to 16% over a 28 
day trial. Cole et al. (1984) later observed increases of 11 to 35% in 
average daily gain during the first 14 days of two trials when the 
protein level was increased from 12.5 to 16%. However, by day 28 no 
differences in gain between the two protein levels were reported. Zinn 
et al. (1983b) showed small, nonsignificant increases in weight gain 
over 28 days when the protein level was increased from 14 to 17%. 
Increasing protein level from 13.3 to 19.3% increased average daily 
gain and feed efficiency by 15 and 7% in a study by Hinman et al. 
(1980). Williams and Mahoney (1984) found no difference in performance 
between rations containing 13.5 and 15.5% protein in two trials 
conducted in 1972 and 1978. Embry (1977) showed the optimum protein 
level in receiving rations to be 13.5%. 
These trials indicate that the protein requirement of newly 
received calves is around 13 to 15%. However, Gillet al. (1980) have 
pointed out that nutrients are required by animals in amounts per head 
per day which may not relate well to the percentage of a nutrient in 
the ration. 
Protein Source. It is generally recommended that urea should 
not be fed to stressed feeder calves. However, the data of Cole and 
Hutcheson (1981) suggest that a ruminal ammonia deficiency can occur 
following a period without feed and water. Williams and Mahoney (1984) 
also indicated that urea provides readily available nitrogen for rumen 
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bacteria and protozoa. Cole et al. (1984) showed that yearling steers 
efficiently utilized dietary urea with a 11% crude protein receiving 
ration of which urea comprised about 7% of the dietary nitrogen. But 
performance suffered when steers were fed a 16% crude protein ration 
with 15% dietary nitrogen from urea. Phillips (1984) observed that 
calves fed a receiving ration with corn gluten meal as the protein 
source and urea providing 20% of the dietary protein had reduced 
performance over the first 28 days, but by day 56 these calves had 
compensated and performed equally with those receiving a soybean meal 
supplement. Gates and Embry (1975) reported that feeding calves 77 
grams of urea per day in four pounds of a 32% protein supplement with 
free choice corn silage reduced feed efficiency 4% as compared to 
calves fed the same diet with no urea. Preston et al. (1975a) reported 
that about 30 grams of urea per day in two pounds of supplement 
decreased gain and efficiency of calves full fed corn silage about 3 to 
5%. Feeding 36 grams of urea in two pounds of ·supplement also reduced 
the weight gain and efficiency of calves fed prairie hay by 17% (Embry, 
1977). These data suggest that urea can be used to supply a portion of 
the supplemental protein for stressed calves. Williams and Mahoney 
(1984) recommended that a maximum of 2.2% of the ration protein could 
be supplied in the form of urea. 
The use of rumen bypass protein in receiving diets for stressed 
calves has received limited attention. Preston and Smith (1974) and 
Preston et al. (1975b) showed that 0.5 to 0.75 pounds of a protected 
soybean meal (formaldehyde treated) was equivalent to about one pound 
of untreated soybean meal in calves fed corn silage. Grigsby (1981) 
reported that calves receiving a 6% corn gluten meal (high bypass 
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protein) ration performed as well as calves receiving an 8% soybean 
meal ration. Phillips and Mclaren (1981) also reported favorable 
performance results with calves receiving a corn gluten meal 
supplement. Calves receiving a ration containing blood meal, corn 
gluten meal, and brewers dried grain gained 11% faster and 14% more 
efficiently than calves receiving cottonseed meal (Zinn et al., 1983b). 
Concentrates. In general, as the concentrate level in the 
receiving diet is increased, weight gains, feed efficiency, morbidity, 
and treatment days per calf will increase {Koers et al.,1975b; Lofgreen 
et al., 1975; Lofgreen et al., 1980). Economically superior results 
have been obtained by newly arrived calves at a concentrate level of 70 
to 75% of the diet. 
Addis et al. {1980c, 1980e) fed calves 72% concentrate diets 
composed of barley, milo, wheat, 50:50 barley-milo combination, or a 
50:50 barley-wheat combination. Performance was equal though calves 
receiving the barley-milo or barley-wheat rations tended to gain faster 
and more efficiently than calves fed other grains. 
Lofgreen and Kirksey {1982) reported that calves receiving a 75% 
concentrate ration during a 28 day receiving period had significantly 
superior gains and gain to feed ratios as compared to calves receiving 
two pounds per day of a 40% protein supplement plus free choice native 
hay for the 28 day period. However, morbidity was slightly lower with 
the hay plus protein supplement diet. Similarly, Lofgreen et al. 
{1984a) observed that during the 28 day receiving period, calves fed 
two pounds daily of a 40% protein supplement plus native hay gained 33. 
fewer pounds than calves fed a 75% concentrate diet plus hay during the 
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first week, but 15 pounds more than calves fed hay alone. During the 
receiving period calves gained more rapidly if fed two pounds daily of 
40% protein pellets plus hay than if fed six pounds daily of 13% 
protein pellets plus hay (Richey et al., 1982). Gillet al. (1982a) 
reported that switching from two pounds daily of a 40% protein pellet 
to three pounds daily of a 13% protein pellet on day 10 of the 
receiving period reduced performance compared to switching to one pound 
daily of the 40% protein pellet. Adverse effects of grain (starch) on 
forage intake and digestion may be responsible. 
These data indicate that the feeding of high concentrate diets 
improves the performance of newly received calves but also increases 
morbidity. Economics will justify the feeding of high concentrate 
rations if the increased medical costs are offset by decreased total 
costs per pound of gain due to increased gains and efficiency. 
Roughages. Lofgreen et al. (1984a) observed that calves 
receiving only native grass hay during a 28 day receiving period 
experienced 65% less morbidity and required 68% fewer treatment days 
than calves receiving a 75% concentrate ration plus native grass hay. 
However, calves fed hay simply maintained their weight while those fed 
concentrates gained 2.15 lbs/day. Similar results with millet hay 
alone or alfalfa hay alone were reported by Lofgreen et al. (1981). 
Calves fed only alfalfa hay performed better than calves fed only 
millet hay. 
Lofgreen et al. (1980) reported that feeding free choice alfalfa 
hay with a 75% concentrate ration during the receiving period reduced 
morbidity and mortality and increased gain and feed efficiency. In 
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contrast, in two other trials, Lofgreen et al. (1975, 1981) found no 
benefit from feeding either. alfalfa hay or millet hay with the 
concentrate ration during the 28 day receiving period. Feeding a 75% 
concentrate ration for the entire receiving period plus either alfalfa 
hay or millet hay for the first week reduced sickness without adversely 
effecting weight gains (Lofgreen et al., 1981). Lofgreen (1982) 
reported that calves fed a 75% concentrate ration for four weeks plus 
oat hay during the first week gained faster and more efficiently than 
calves receiving alfalfa hay during the first week. 
Davis (1978) reports that newly received calves experience less 
sickness and require less feed per pound of gain when fed ground 
alfalfa as compared to corn silage during the first 28 days in the 
feedlot. In a three year project with Canadian feedlots (Martin et 
al., 1982) when corn silage was the major roughage, morbidity and 
mortality were increased. In contrast, in Ohio studies (Preston et 
al., 1973; Preston and Kunkle, 1974; Kunkle et al., 1976) calves fed a 
poor quality hay had higher gains during the first week after arrival 
than calves fed corn silage, but lower gains after the first week. 
These data indicate that feeding a roughage such as alfalfa to 
calves during the first week of the receiving period reduces morbidity 
without reducing gains and efficiency. Hence, this practice is 
economically advantageous. A sequence of feeding hay plus protein 
supplement early and a 75% concentrate diet later may optimize health 
and performance. 
Minerals. Very little data is available on the mineral 
requirements of stressed calves. However, recent research evaluated 
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the level of potassium required for newly received calves. Zinn et al. 
(1983a) suggested that potassium supplementation influences the animal 
in three ways: 1) Increased water retention; 2) Enhanced ruminal 
digestion, particularly of fiber; and 3) Modulated feed consumption 
patterns. Calves undergo dehydration during shipment and severe 
dehydration may limit the efficiency of the immune system. Since 
potassium supplementation increases water retention, animal health also 
might improve. 
Hutcheson et al. (1978) reported that increasing the potassium 
level of the diet of newly received feeder steers from 1 to 1.5% did 
not effect morbidity, but increased gains by 15% (P<.05) in the first 
28 days. In contrast, Cole and Hutcheson (1982) reported that 
increasing the potassium level of the diet of new feedlot arrivals from 
0.8% to 1.3% did not affect rate of gain, but reduced mortality by 47%. 
Later, Hutcheson et al. (1984) observed reduced morbidity and 
mortality by increasing the potassium level from 0.9% to 1.4%. 
Williams and Mahoney (1984) reported that gains and feed efficiency 
have been improved by increasing the potassium level from 0.8 to 1.4%. 
In contrast, no benefits were found from increasing the potassium level 
from 1% to 1.5% in a study by Zinn et al. (1983a). 
Vitamins. Research has shown that injections of vitamins A and 
D generally slightly improve daily gains and feed efficiency in 
stressed calves but tend to increase morbidity and mortality (Davis et 
al., 1975; Davis, 1978, 1980; Davis and Caley, 1978, 1981). These 
workers also have shown that adding an injection of vitamin s12 with 
vitamins A and D tended to decrease performance and increase sickness 
as compared to injections of vitamins A and D alone. 
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Studies which have examined the effect of feeding B-vitamins on 
the health and performance of stressed calves have produced 
inconsistent results. Brethour and Duitsman (1972) and Cole et al. 
(1982) reported that feeding of B-vitamins tended to reduce sickness 
and improve the performance of stressed calves. Though feeding 
B-vitamins increased sickness in calves weaned 30 days prior to 
shipment, it reduced sickness in calves weaned at shipment (Cole et 
al., 1982). Williams and Mahoney (1984) reported that feeding of 
B-vitamins decreased performance in calves. The addition of B-complex 
vitamins and vitamin E to the diet increased weight gains and feed 
efficiency in newly received calves, by 11% and 15%, respectively (Lee 
et a 1. , 1985) • 
Tengerdy (1980) reviewed the effects of vitamin E on immune 
responses and concluded that supplementing vitamin E in pharmacological 
doses in well balanced diets increased humoral antibody production 
against a variety of particulate and soluble antigens. This effect was 
noted in chickens, mice, turkeys, guinea pigs, and rabbits. Dietary 
supplementation of vitamin E enhances the humoral immune response of 
sheep against Clostridium perfringes (Tengerdy et al., 1983). 
Vitamin E has been shown to increase disease protection in chickens 
against E. coli infection (Heinzerling et al., 1974a) and in mice 
against D. pneumonia infection (Heinzerling et al., 1974b). Studies 
have also shown that high levels of vitamin E may enhance the immune 
system of swine (Ellis and Vorhies, 1976) and horses (Lewis et al., 
1976). Smith et al. (1984) reported that vitamin E supplementation 
reduced the incidence and duration of clinical mastitis in dairy cows 
by 37% and 44%, respectively. 
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Perry et al. (1968) reported that vitamin E supplementation had no 
effect on weight gains of feedlot calves. Newland et al. (1966), 
Lyford and Col by (1967) and Totusek et al. (1968) noted that vitamin E 
injections had no effects on gains of feedlot calves. In contrast to 
these studies, Lee et al. (1985) reported that vitamin E 
supplementation (400 IU/head/day) of the receiving diet of 418 stressed 
calves improved daily gains and feed efficiency by 5% and reduced 
morbidity and mortality by 8% and 50%, respectively. The addition of 
B-complex vitamins and vitamin E to the diet increased weight gains and 
feed efficiency by 11% and 15%, respectively. 
Coccidiostats. Coccidiosis in cattle is a disease caused by 
Eimeria spp. These are intercellular host-specific parasites that 
occur in most animals. Coccidiosis is seen more frequently during the 
cool and wet seasons of the year. It is transmitted by oocysts present 
in the feces which are picked up from consuming contaminated feed or 
water or licking contaminated materials. The disease reduces feed 
consumption and performance and causes mucoid diarrhea and occasionally 
death due to dehydration. 
Coccidiosis causes large economic losses not only from morbidity 
and death, but also from high treatment cost, reduced feed efficiency, 
and weight gains. The response of cattle to a coccidiostat depends on 
their health status. Fox (1984) reviewed recent field data and 
concluded the following: 1) Low level or subclinical coccidiosis 
caused serious economic losses and interfered with optimum performance, 
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2) The severity of the symptoms of coccidiosis was both affected by and 
contributed to stress, and 3) Medication with a coccidiostat removed 
one of the stresses associated with cattle husbandry and helped reduce 
the severity of other diseases. 
Much of the recent coccidiosis research has concerned the 
coccidiostat, decoquinate. Hutcheson and Cummins (1982) reported that 
including decoquinate in the starting diet of stressed calves for 28 
days improved gains and feed efficiency by 10% and 24%, 
respectively, while reducing morbidity by 6% and mortality by 37%. 
Barnes et al. (1984) reported that yearling heifers receiving 
decoquinate at 30 mg/100 lb body weight while grazing native grass 
pasture gained 20% faster (2.97 vs 2.47 lb/day) than the control group 
not fed decoquinate. In another trial, control heifers gained 5% 
faster (2.91 vs 2.76 lb/day) than those head receiving decoquinate. 
Barnes et al. (1985) in a subsequent report examined the effect of 
decoquinate (23 mg/100 lbs body weight) in two trials with 201 heifers 
receiving low quality grass hay plus two pounds daily of a 38% protein 
supplement. In both trials, decoquinate significantly increased daily 
gains over a 58 day period (. 79 vs • 34 1 bs/day and • 57 vs .03 1 bs/day) 
and reduced morbidity (38 vs 54% and 16 vs 65%). Lusby et al. (1985) 
found decoquinate increased weight gains by 26% (1.34 vs 1.06 lbs/day) 
and reduced morbidity by 29% (34.7 vs 49.0%) in a 56 day trial with 
heifers fed wheat hay and crabgrass hay plus two pounds daily of a 38% 
cottonseed meal based supplement. 
Fox (1984) reported the results of a field trial in which 
decoquinate increased daily gains of calves by 12% (.5 vs .56 kg/day), 
increased feed efficiency by 26%, reduced morbidity by 6%, and reduced 
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mortality by 37% over a 28 day period. In another field trial, 
morbidity and mortality were reduced by 18% and 29%, respectively, with 
decoquinate. 
Other studies have reported that including decoquinate in the diet 
of newly received calves did not alter the performance or health status 
of the calves (Prouty et al., 1981; Rust et al., 1981; Williams and 
Mahoney, 1984). This may reflect reduced drug effectiveness, reduced 
incidence of coccidiosis, or less stress. 
Recently the ionophores, monensin and lasalocid, have been tested 
as coccidiostats in the diets of newly-arrived, stressed calves. Wray 
et al. (1984) reported that monensin controlled or reduced clinical 
signs of coccidiosis and Horton (1982) reported that lasalocid at 
sufficiently high levels is an effective coccidiostat for cattle. 
Addis et al. (1980d) investigated the effects of monensin fed at 
four levels on the health and performance of 445 newly arrived calves 
during a 56 day trial. Addition of monensin to the receiving diet 
increased weight gain and feed efficiency by 6.3% and 6.7%, 
respectively, but had no effect on incidence of sickness. Results were 
best with monensin at 10 grams per ton of feed during the first two 
weeks and 30 grams per ton during the last five weeks (with which gains 
and efficiency were improved by 7.5% and 7.7%, respectively). 
Embry (1977) reported that the overfeeding of monensin during 
periods of stress could reduce feed intake by light calves during this 
critical time and thereby cause additional stress. Addis et al. 
(1980e) reported that feed intake by calves was significantly reduced 
during the first two weeks of the receiving period when monensin was 
fed at 30 grams per ton of feed and morbidity was increased by 12%. 
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Hence, the level of monensin recommended during the first two to three 
weeks that calves are on feed is 10 or 20 grams per ton of feed (Embry, 
1977). 
Lusby et al. (1984) examined the effects of decoquinate and 
monensin (100 mg/day) on the performance of weaned calves grazing 
native grass pasture and receiving 0.8 pounds daily of soybean meal 
supplement. After seven days of feeding, both drugs significantly 
reduced the number of fecal coccidia, but decoquinate was slightly more 
effective. No clinical signs of coccidiosis were noted during the 63 
day trial. Calves receiving soybean meal plus monensin gained 15% more 
than those receiving no coccidiostat, while calves receiving 
decoquinate gained only 1% faster than those receiving no coccidiostat. 
Lasal oci d fed at 30 grams per ton of feed improved the feed 
efficiency of newly arrived feedlot calves by 16.8% (Davis, 1982). 
Gill et al. (1982b) reported that adding lasalocid (50 mg/lb) to a 10% 
protein pellet fed at two pounds per head daily increased weight gain 
by 7.8% for steers grazing native grass pasture for 97 days. No signs 
of coccidiosis were observed in this trial. 
These data indicate that feeding coccidiostats may improve weight 
gains and feed efficiency and decrease morbidity of newly received 
calves. The response of calves to a coccidiostat depends on the level 
of coccidiosis infection and the degree of stress the calves are 
subject to. These data also indicate that even subclinical coccidiosis 
reduces performance of calves, thereby, increasing economic losses. 
Under conditions in which calves are heavily stressed and feed intake 
is likely to be low, the feeding of decoquinate during the stress 
period followed by the feeding of monensin or lasalocid during the 
growing phase might be desi_rable. 
Anthelmintics 
Performance responses to anthelmintics by newly received stocker 
cattle have been variable. An anthelmintic is useless if the calves 
have minimal parasite burden or if it is ineffective against those 
parasites present. The pathogen of greatest economical importance to 
cattle is the abomasal nematode, Ostertagia ostertagi. This review 
will focus largely on this parasite and its control. Recognition and 
control of this parasite was recently reviewed by Williams et al. 
(1984). 
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To control this parasite in stocker calves, its life cycle must be 
considered. As with most gastrointestinal nematodes which infect 
cattle, the Ostertagia ostertagi eggs are shed in the feces. These 
eggs hatch and develop to the third larval (infective) stage in as few 
as seven days during the summer, but may require several weeks during 
the winter. Infective larvae are ingested with forage as an animal 
grazes. Larvae burrow into glandular tissue of the abomasum and molt 
to the fourth larval stage about four days later. In its normal life 
cycle, the parasite grows and molts to the early adult or fifth stage 
by 10 to 12 days after infection. Then they emerge from the mucosal 
tissue as adults and mate. Damage to the mucosa as young adults emerge 
causes diarrhea, weight loss, and reduced feed intake. This cycle 
continues only during seasons of the year which are favorable for 
development and survival of free-living stages on pasture. During 
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seasons adverse to the free-living stage, the fourth stage larva remain 
in a state of inhibition. 
Williams et al. (1984) reported that there are three ostertagia 
disease types. Type I ostertagiasis is due to rapid accumulation of 
large numbers of larvae which develop to adults in the normal three 
week cycle. Type I disease is thought to be common during late winter 
and early spring in southern temperate regions of the United States. 
Nearly any broad spectrum anthelmintic is effective at this time. 
Pre-type II ostertagiasis encompasses the time period in which 
conditions are unfavorable for the early fourth stage larvae to develop 
further. Generally, no clinical effects are apparent at this time. In 
Oklahoma, this condition occurs during spring to late summer. At this 
inhibited stage, larvae are not effected by the traditional 
anthelmintics such as thiabendazole, levamisole, or morantel tartrate. 
Type II ostertagiasis is caused by the mass maturation of large 
numbers of inhibited larvae. This disease occurs when parasitic 
problems are least expected, late summer through autumn in southern 
temperate climates. The presence of severe clinical disease is usually 
low in the type II phase, but may cause high death loss in those few 
severely affected animals. The traditional anthelmintics have limited 
effect because such treatment only removes adult worms and may cause 
maturation of another wave of larva. 
Animal performance responses to anthelmintics such as 
thiabendazole, 1 evami sole, or moran tel tartrate by stocker calves have 
been variable. Davis et al. (1976) reported daily gain and feed 
efficiency were improved by 41 and 28%, respectively, with their use in 
192 feeder calves. In a sunrnary of four trials involving 936 calves, 
Davis and Caley, (1979) reported that anthelmintics increased weight 
gains and feed efficiency by 19.2% and 11.1%, respectively, while 
reducing sickness by 11.9%. This contrasts with results of Hanke and 
L indor (1983) and of Winder et al. (1983) who detected no improvement 
in performance of feeder calves from treatment with the traditional 
anthelmintics. 
44 
Promising results have been reported with the use of a new 
anthelmintic, ivermectin. It has been shown to be over 99% effective 
against inhibited larvae of Ostertagia ostertagi (Williams et al., 
1981) while traditional anthelmintics are ineffective against this 
stage. In addition, ivermectin is efficacious (over 99%) against all 
types of gastrointestinal nematodes found in the abomasum, small 
intestine, cecum, and large intestine (Yazwinski et al., 1981; Benz, 
1983). Smith (1984) reported that research data indicate that 
ivermectin is effective against other parasites as well, including the 
adult and larval stages of essentially all pulmonary and 
gastrointestinal nematodes, the parasitic stages of the common cattle 
grub, the cattle sucking lice, the cattle mange mites, several s~ecies 
of ticks, and the larval stages of horn and face flies. 
Holste (1983) reported that ivermectin increased daily gains of 
calves fed a mixture of corn and alfalfa hay for a 110 day period by 
11.3%. Ciordia et al. (1984) observed that ivermectin improved weight 
gains of calves grazing a fescue and bermuda grass pasture by 21%. 
Lofgreen et al. (1984c) compared the effects of ivermectin and 
levamisole on performance of newly received calves. Calves receiving 
ivermectin gained 14% and 6% faster over 28 days and 56 days, 
respectively, as compared to those head treated with levamisole. In a 
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subsequent trial, however, Lofgreen et al. (1984d) reported that calves 
treated with ivermectin gained significantly less weight over a 56 day 
period than calves treated with levamisole. These data indicate that 
ivermectin will increase the gains of newly received calves more 
consistently than the traditional anthelmintics since ivermectin is 
highly effective against inhibited larvae of Ostertagi ostertagi. 
CHAPTER III 
THE EFFECT OF MASS MEDICATION ON HEALTH AND 
PERFORMANCE OF NEWLY ARRIVED 
STOCKER CATTLE 
Summary 
A total of 1437 newly received steer and bull calves and yearlings 
were used in studies to determine the effectiveness of certain mass 
medication procedures for reducing morbidity due to shipping fever. In 
one experiment, 1046 head averaging 215 kilograms were divided into two 
groups: one received routine processing on arrival and the other 
received routine processing plus long-acting oxytetracycline (LAO) and 
sustained release sulfadimethoxine (SRS). Morbidity was reduced 
(P<.0001) from 33.2% in the non-mass medicated cattle to 14.6% in·those 
receiving mass medication at processing. The 523 head of non-mass 
medicated cattle had 1177 sick pen days, while the 523 mass medicated 
cattle had 424 sick pen days, a reduction (P<.0001) from 2.25 to .81 
sick days per head. Mass medication improved (P<.05) average daily 
gains and gain to feed ratios by 7.6% (.71 vs .66 kg/head) and 11.2% 
(.119 vs .107 kg gain/kg feed), respectively. 
In the second experiment, 391 head averaging 210 kilograms were 
divided into four groups: 1) Control (routine processing only), 2) 
LAO, 3) SRS, and 4) LAO plus SRS. Mass medication with LAO, SRS, and a 
combination of the two drugs reduced morbidity by 22.1, 10.1, and 
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11.0%, respectively. The number of sick days per head was reduced by 
LAO (P<.OS, 2.56 days) and LAO plus SRS (3.35 days) as compared to the 
controls (4.34 days). Mass medication had no effect on average daily 
gains but reduced feed intake (P<.lO). 
Introduction 
Between two and five percent of newly arrived stocker cattle 
received in Oklahoma die of stress related diseases, primarily the 
shipping fever-bovine respiratory disease complex (BRD), shortly after 
shipping (Gill, 1985). Morbidity ranges from 0 to 100 percent, with an 
average probably between 25 and 30 percent. Cattlemen receiving 
stressed cattle must be prepared with a complete health program to 
prevent excessive death loss and decreased performance. Because 
treating BRO is costly, it may be cheaper to prevent its occurrence 
rather than treat it (NCA, 1979). The administration of intramuscular· 
oxytetracycline for the first three days after arrival of stressed 
calves in the feedlot has been shown to reduce the incidence of BRD, 
but this treatment is not always cost effective (Addis et al., 1976; 
Lofgreen, 1978; Lofgreen, 1983). A disadvantage to this type of 
program is that all calves must be run through the chute for three 
successive days, increasing labor costs. Recently developed 
long-acting oxytetracycline and sustained release sulfas eliminate the 
need of running calves through the chute for three successive days. 
Lofgreen (1983, 1984b) reported that the administration of both of 
these drugs to stressed calves at time of arrival reduced morbidity by 
90%. The administration of LAO alone has also been shown to reduce 
morbidity due to BRD in stressed calves (Janzen and McManus, 1980; 
Davis and Carley, 1981; Swafford et al., 1983). 
The objective of this study was to evaluate the effect of mass 
medication with long-acting oxytetracycline and/or sustained release 
sulfadimethoxine on the health and performance of newly arrived, 
stressed stocker cattle. 
Experimental Procedure 
Experiment One 
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Eleven truck loads of cattle in six different months (designated 
as trials) were assembled by order buyers with the majority coming from 
auction barns in the southeastern United States and shipped to 
Pawhuska, Oklahoma. The origin, arrival date and weight, number of 
head, and in-transit shrink for each load is summarized in Table I. 
Newly received cattle were weighed individually off the truck, ear 
tagged, and poured with famphur systemic insecticide. Following 
weighing and tagging, cattle were placed in one of nine pens of 20 to 
25 animals each, depending on the number of cattle received. Pens were 
randomly assigned to mass medication (MM) or non-mass medication (NMM) 
groups. Water and native bluestem grass hay were provided free choice. 
On the morning following arrival, cattle were processed by pen as 
follows: 
1. Body temperature and time were recorded. 
2. Cattle were vaccinated with IBR-PI 3 (MLV) IM, Leptospira 
pomona bacterin, and Clostridia chauvoei, septicum, novyi, 
and sordellii bacterin. 
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TABLE I 
ORIGIN, ARRIV~ DATE, NUMBER OF HEAD, ARRIVAL WEIGHT 
AND IN-TRANSIT SHRINK FOR EACH LOAD OF CATTLE--
MASS MEDICATION EXPERIMENT ONE 
Arrival Number Arrival % Origin Date of Head Wt., kg Shrink 
Trial 1 
Truck 1 FL 9-15-83 101 195 11.3 
Trial 2 
Truck 2 OK 10-20-83 95 200 8.5 
Truck 3 FL 10-20-83 91 220 10.0 
Trial 3 
Truck 4 OK 12-01-83 104 200 NAa 
Truck 5 OK 12-08-83 88 200 NAa 
Trial 4 
Truck 6 TN 1-10-84 93 223 7.0 
Truck 7 TN 1-12-84 99 219 7.0 
Trial 5 
Truck 8 AK 2-18-84 79 242 6.5 
Truck 9 AK 2-24-84 90 245 6.0 
Trial 6 
Truck 10 MO 3-21-84 101 215 8.0 
Truck 11 MO 3-28-84 105 221 NAa 
aNA=not available. 
3. Dewormed with levamisole gel. 
4. Cattle in the MM group received an injection of long-acting 
oxytetracycline1 (22 mg/kg) and sustained release sulfadimethoxine 
boluses 2 (1 bolus-12.5 g/91 kg of body weight). 
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5. Cattle in the NMM group received antibiotic treatment if 
clinical signs of illness were detected or if body temperature exceeded 
40°C. 
6. Hospital card was initiated (NMM). 
7. Animals from the NMM group which were not sick and all MM 
cattle (sick or well) were returned to their home pen. Sick animals 
from the NMM group were placed in the hospital pen. 
As soon as cattle were placed in their pens, they had ad libitum 
access to prairie hay and were offered a pelleted feed supplement 
(Table II) at a rate of • 9 kg/head/ day for the first 21 days and • 45 
kg/head/day during days 22-28. The supplements contained 1) no added 
drugs, 2) lasalocid3 (165 mg/kg), or 3) decoquinate4 (110 mg/kg). 
Three hospital pens were maintained so that sick animals received their 
assigned feed while out of their home pen. 
Mass-medication was assigned at random to either four or five pens 
in each trial with non-mass medicated cattle being placed in the 
remainder of the nine pens. In each trial, each feed medication was 
1 . LA-200®, Pfizer, Inc., New York, NY 10017. 
2Albon-SR®, Hoffman-LaRoche, Inc., Nutley, NJ 07110. 
3Bovatec®, Hoffman-LaRoche, Inc., Nutley, NJ 07110. 
4oeccox®, Rhone-Poulenc, Inc., Monmouth Junction, NJ 08852. 
Ingredient 
Soybean Mea 1 
Salt 
Vitamin A - 30,000 
p . b rem1x 
Cottonseed Meal 
Dicalcium Phosphate 
TABLE II 
COMPOSITION OF FEED SUPPLEMENT 
IFNa 
5-20-637 
6-04-152 
IU/Gram 
5-01-621 
6-01-080 
% As Fed 
88.9 
3.0 
• 22 
.18 
s. 0 
2.75 
~nternational Feed Number. 
o provide: 0 for control~ 165 mg lasalocid/kg, or 110 mg decoq ui nate/ kg. 
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fed to at least one pen. Numbers of pens assigned to treatment were 
balanced between trials. 
After processing, cattle were checked twice daily for signs of 
illness. If an animal was suspected to be sick, it was taken to the 
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processing area where its body temperature was measured and a severity 
of illness score (slight, moderate, or severe) was assigned. If the 
body temperature exceeded 40°C the animal was considered sick. The 
animal could also be classified as sick based on clinical signs. 
Cattle receiving mass medication were not removed from their pen if 
they were detected as sick within the first 24 hours after processing. 
Medical treatment for sick animals was determined by the ear tag 
number which was applied at random on arrival. Treatment schedules 
assigned to non-mass medicated cattle were: A) no treatment (negative 
controls), B) a sequence of antimicrobial drugs (Table III), or C) an 
experimental potentiated sulfa (ROS-00375). Cattle treated by 
schedule B were initially treated with the first drug in the sequence. 
If body temperature dropped 1.1°C or to less than 40°C, or clinical 
signs were improved within 24 hours, the first drug was continued for 
two more days. If no improvement was apparent within 24 hours, the 
next drug in the sequence was used and the process was repeated until 
improvement was detected. In trials 3, 4, and 5, drug treatments 1 and 
3 were reversed so that the first treatment was amoxicillin. Cattle 
treated by schedule C received R05-0037 boluses orally at 66 mg/kg on 
day one and 33 mg/kg on days 2-5, regardless of response to therapy. 
If additional treatment was required at the end of the 5 day treatment, 
5Primor®, Hoffman-LaRoche, Inc., Nutley, NJ 07110. 
TABLE III 
SEQUENCE OF DRUGS USED FOR TREATMENT OF BRD--
1983-1984 EXPERIMENTS 
Treatment No 1: OXYTETRACYCLINE (Biomycin-C®) subcutaneously -
11 mg/kg. 
Treatment No 2:a 
Treatment No 3:a 
Treatment No 4:a 
Treatment No 5:a 
Treatment No 6:a 
Plus 
SULFAMETHAZINE BOLUSES (Sulmet® - 15 gm) 1 
bolus/68 kg on day 1. One bolus/136 kg on 
subsequent days. 
ERYTHROMYCIN (Gallamycin®) deep in the 
muscles - 22 mg/kg 
AMOXICILLIN (Amoxi-ject®) subcutaneously 11 
mg/ kg. 
Procaine Penicillin G subcutaneously- 66,000 
IU/kg 
TYLAN 200 - 22 mg/kg. 
SPECTINOMYCIN (Spectam®) - 11 mg/kg. 
aSome of the antimicrobial drugs used in this study were used for 
extra-label purpose or at extra-label dosages and require a 
veterinarian-client-patient relationship before use. 
53 
54 
cattle were started on the second drug in the sequence (Table III). 
Any mass medicated cattle detected as sick were treated initially with 
the second drug in the antibiotic sequence. 
At the end of the 28 day trial! the cattle were held overnight 
without feed or water! weighed the following morning and! as necessary! 
cattle were castrated and horns were tipped. Cattle were then returned 
to the owner. 
Experiment Two 
Four truck loads (four trials) of cattle were assembled by order 
buyers from auction barns in Alabama! Tennessee! or Texas and shipped 
to Pawhuska, Oklahoma. The origin, arrival date and weight! number of 
head! and in-transit shrink for each load is summarized in Table IV. 
Newly received cattle were weighed individually off the truck and 
treated with Lysoff®6• Following weighing and tagging, cattle were 
placed in pens of 20 to 25 animals each depending on the number of 
cattle received. Cattle were randomly assigned by pen to one of the 
following treatments: control! receiving no preventative medication; 
intramuscular injection of long-acting oxytetracycline at a rate of 22 
mg/kg; oral administration of sustained release sulfadimethoxine at a 
rate of 12.5g (one bolus)/91 kg; or administration of both drugs. 
Water and native bluestem grass hay were.available free choice. The 
morning following arrival! the cattle were processed in the same manner 
as those in experiment one with the following exceptions: 1) Cattle 
6cutter Laboratories! Shawnee Mission, KS 66201. 
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TABLE IV 
ORIGIN, ARRIVAL DATE, NUMBER OF HEAD, ARRIVAL WEIGHT 
AND IN-TRANSIT SHRINK FOR EACH LOAD OF CATTLE--
MASS MEDICATION EXPERIMENT TWO 
Arr iva 1 Number Arrival % 
Trial Origin Date of Head Wt., kg Shrink 
1 TN 8-12-84 100 180 NAa 
2 AL 9-28-84 100 207 7.6 
3 AL 11-03-84 95 221 NAa 
4 TX 12-06-84 96 230 4.3 
aNA=not available. 
with odd-numbered ear tags were dewormed with ivermectin 7 (200mcg/kg) 
and those with even-numbered ear tags served as controls as part of a 
deworming trial superimposed on this study and 2) Cattle receiving 
preventative medication were treated with their respective drugs. 
As soon as cattle were placed in their pens, they had ad libitum 
access to prairie hay and were offered a pelleted feed supplement 
(Table II - with lasalocid) at a rate of .9 kg/head/day for the first 
21 days and .45 kg/head/day during days 22-28. 
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After processing, cattle were checked twice daily for signs of 
illness as described in experiment one. Calves receiving preventative 
medication were not pulled if they were detected as sick within the 
first 48 hours of the trial. Sick cattle were assigned to medication 
schedule B (Tab 1 e II I ) beginning with Treatment 2. In this experiment, 
spectinomycin replaced am oxic ill in as Treatment 3. Response to drug 
treatment was measured in the same manner as it was in experiment one. 
At the end of the 28 day trial, the cattle were held overnight 
without feed or water, weighed the following morning and, as necessary, 
cattle were castrated and horns were tipped. Cattle were then returned 
to the owner. 
Statistical Analysis 
Least squares analysis of variance was performed on data for all 
response criteria within each experiment using the General Linear Model 
of the Statistical Analysis System (SAS). In experiment one, the 
initial models across all cattle for weight gains, sick days, 
7Ivomec®, MSD Agvet, Rahway, NJ 07065. 
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morbidity, and mortality included truck, feed treatment, medical 
treatment (mass vs non-mass medication), all two way interactions, and 
initial weight. 
In experiment two, the initial models for weight gains, sick days, 
morbidity, and mortality across all cattle included trial, medical 
treatment, worming treatment, all two way interactions, and initial 
weight. The initial models for weight gains, sick days, repulls, and 
response to first drug treatment in the sick cattle included the same 
sources of variation as the models for all cattle. 
In both experiments, data on feed intakes and gain to feed ratios 
were analyzed using pens as the experimental unit since feed records 
were kept on a pen basis. The initial models for these two criteria in 
experiment one included trial, feed treatment, medical treatment, all 
two way interactions, and initial pen weight. The initial models for 
these two criteria in experiment two included trial, medical treatment, 
and initial pen weight. 
In both experiments, the initial models were reduced when sources 
of variation had observed significance levels greater than .20. 
However, medical treatment was included in all models since it was the 
source of variation being studied. 
Results and Discussion 
Experiment One 
Effects of mass medication with long-acting oxytetracycline and 
sustained release sulfadimethoxine on daily gains, sick days, 
morbidity, and mortality are shown in Table V. Gains in the 28 day 
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receiving period were significantly increased (P<.05) by mass 
medication (.71 vs .66 kg/head/day). Gains of those cattle that were 
never sick were .74 and .77 kg/head/day for the NMM and MM groups, 
respectively. The number of sick days per head was reduced (P<.0001) 
by 64% (.81 vs 2.25 days/head) and morbidity was reduced (P<.0001) by 
56% (14.6 vs 33.2%) with the administration of mass medication. These 
reductions in morbidity and hospital pen days and improvements in gains 
are consistent with results reported by Lofgreen (1983, 1984b). Death 
loss in this experiment was .76% in both control cattle and mass 
medicated cattle. Another factor influencing (P<.0001) weight gains, 
sick days, and morbidity was truck load. Apparently, the response of 
cattle to mass medication was dependent on such factors as the origin 
of the cattle and degree of previous stress. 
Effects of mass medication on feed intake and gain to feed ratio 
are reported in Table VI. Mass medication reduced feed intakes (P<.01) 
from 6.67 to 6.24 kilograms per head per day. This 6.4% reduction in 
feed intakes combined with the 7.6% increase in daily gains with mass 
medication resulted in an improvement in gain to feed ratio of 11.2% 
(P<.05, .119 vs .107 kg gain/kg feed). 
Experiment Two 
Effects of mass medication with long-acting oxytetracycline, 
sustained release sulfadimethoxine, or a combination of the two drugs 
on daily gains, sick days, morbidity, and mortality in cattle in 
experiment two are reported in Table VII. None of the mass medication 
procedures altered (P>.05) average daily gains of the cattle. However, 
the cattle treated with SRS tended to have lower gains than all other 
TABLE V 
EFFECT OF MASS MEDICATION ON DAILY GAINS, 
SICK DAYS, MORBIDITY AND MORTALITY IN 
STRESSED CATTLE--EXPERIMENT ONE 
Number of head 
Number of head never sick 
Arrival weight, kg 
* Daily gain, kg 
* Daily gain of head never sick, kg 
* Sick days 
* Morbidity, % 
Total Mortality, % 
Mortality excluding treatment 
schedule A cattle, % 
* 
Controls Mass 
523 
352 
216 
• 66a 
• 74 
2.25d 
33.2d 
0.76 
0.38 
bExpressed as LSMEANS. 
a, d~eans with different superscripts differ (P<.OS). 
c,lMeans with different superscripts differ (P<.0001). 
TABLE VI 
EFFECT OF MASS MEDICATION ON FEED INTAKE AND GAIN TO FEED RATIO--EXPERIMENT ONE 
Medication 
523 
442 
215 
.71b 
.77 
0.81c 
14. 6c 
0.76 
0.76 
Controls Mass Medication 
Number of pens 
* Feed intake, kg 
* kg gain/ kg feed 
* 
26 
6.67b 
0.107c 
bExpressed as LSMEANS. 
a, n~eans with different superscripts differ (P<.01). 
c,lMeans with different superscripts differ (P<.05). 
25 
6.24a 
0.119d 
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TABLE VII 
EFFECT OF MASS MEDICATION ON DAILY GAINS, 
SICK DAYS, MORBIDITY AND MORTALITY IN 
STRESSED CATTLE--EXPERIMENT TWO 
Controls LAO SRS 
Number of head 98 98 98 
Number of head never sick 39 52 45 
Arrival weight, kg 209 210 210 
* Daily gain, kg • 64 • 62 • 52 
Daily gain of 
* head never sick, kg • 75 .77 • 72 
* 4. 34b 2.56a 4.24b Sick days 
Morbidity, %* 60.2 46.9 54.1 
Mortality, % 3.1 1.0 6.1 
* bExpressed as LSMEANS. 
a, Means with different superscripts differ (P<.05). 
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LAO + SRS 
97 
45 
209 
• 62 
.82 
3. 35ab 
53.6 
2.1 
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cattle. Mass medication with a combination of LAO and SRS tended to 
improve gains of cattle that were never sick (.82 vs .75 kg/head/day). 
Mass medication with LAO reduced (P<.05) the number of sick days per 
head by 41% (2.56 vs 4.34 days/head). A combination of LAO and SRS 
reduced (P>.05) the number of sick days per head by 22.8% (3.35 
days/head). Administration of SRS alone did not affect the number of 
sick days per head (4.24 days). Morbidity was high in this experiment 
and all of the mass medication procedures only reduced it slightly. 
The greatest reduction in morbidity occurred with LAO (P<.05) which 
reduced it by 22.1% (46.9 vs 60.2%). In contrast to the results of 
experiment one, mass medication with LAO plus SRS in this experiment 
did not greatly reduce hospital pen days or morbidity. 
Effects of the various mass medication treatments on the 
performance and health of the sick cattle in this experiment are 
summarized in Table VIII. All three of the mass medication procedures 
tended to reduce the daily gains of the sick cattle with SRS reducing 
(P<.05) gains by 42.7% (.34 vs .59 kg/day). Weight gains were reduced 
by 22% and 23.7%, respectively, by LAO and LAO plus SRS. The number 
of treatments per sick head was increased by 17.6% with SRS (8.36 vs 
7.11 days/head), whereas, LAO and LAO plus SRS reduced the number of 
treatments by 19.8% and 5.6%, respectively. Number of repulls (cattle 
that had to be treated more than once for respiratory disease) was 
significantly reduced (P<.Ol) by the administration of LAO (6.1 vs 
26.9%) but repulls were increased by SRS by 48.7% (40.0 vs 26.96%). 
The response to first drug treatment was similar across groups except 
that SRS reduced response rates by 29.4% (50.0 vs 70.8%). 
Feed intakes and gain to feed ratios for the four treatment groups 
TABLE VI II 
EFFECT OF MASS MEDICATION ON DAILY GAINS, SICK DAYS, 
REPULLS AND RESPONSE TO FIRST TREATMENT 
IN SICK CATTLE--EXPERIMENT TWO 
Controls LAO SRS 
Number of head 59 46 53 
Daily gain, kg * • 59b .46ab • 34 a 
* 7.11 cd 5.70c 8.36de Sick days 
Repulls, % * 26.9de 6.1c 40.0e 
* Response to first 
treatment, % 70.8 76.8 50.0 
* bExpressed as LSMEANS. ~' Means with different superscripts differ (P<. 05). 
c, ,eMeans with different superscripts. differ (P<. 01). 
TABLE IX 
EFFECT OF MASS MEDICATION ON FEED INTAKE AND 
GAIN TO FEED RATIO--EXPERIMENT TWO 
Controls LAO SRS 
Number of pens 4 4 4 
. * Feed 1ntake, kg 6. 71 b 5.96a 6.18a 
kg gain/kg feed * .101 .103 • 086 
* a bExpressed as LSMEANS. 
' Means with different superscripts differ (P<.10). 
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LAO + SRS 
52 
.45ab 
6. 71 c 
20. 7cd 
65. 7 
LAO + SRS 
4 
6.09a 
.105 
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are reported in Table IX. All three mass medication procedures reduced 
feed intake (P<.lO) as compared to the control cattle. Gain to feed 
ratios were not altered by the administration of LAO or LAO plus SRS 
but were reduced by 14.9% with SRS medication. 
Discussion 
Mass medication with long-acting oxytetracycline and sustained 
release sulfadimethoxine improved weight gains and reduced sick pen 
days and morbidity in stressed cattle in experiment one. However, this 
same procedure did not effect the performance or health of cattle in 
experiment two. These results did not agree with those expected. With 
higher morbidity, one would expect mass medication to be of greater 
benefit than for cattle experiencing little sickness. 
Neither of these long-acting drugs maintain therapeutic blood 
levels past four days. Hence, mass medication would have limited 
benefit if the majority of the cattle became sick after the first week 
of the receiving period. But, in both of these experiments, the 
majority of the cattle requiring treatment were pulled within the first 
four days following processing. Thus, delayed sickness cannot account 
for the difference in response observed between the two experiments. 
In experiment two, the administration of LAO alone reduced the 
incidence of sickness, the number of sick days per head, and the number 
of repulls. Since LAO costs only one-half as much as mass medication 
with both LAO and SRS, its use would be more likely to be economically 
advantageous. The administration of SRS alone tended to impair the 
health and performance of these newly arrived cattle. 
The economics of mass medicating cattle depends on the cost and 
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success of conventional treatment, availability of labor, ability to 
detect sick cattle early, and on the health status of cattle received. 
Mass medication at processing would not be economic for fresh, local 
cattle which experience delayed illness (7-14 days after arrival). 
Mass medication should reduce labor and drug costs, and increase 
performance for cattle which are severely stressed from a long trip. 
CHAPTER IV 
THE EFFECT OF LASALOCID OR DECOQUINATE ON HEALTH 
AND PERFORMANCE OF NEWLY ARRIVED 
STOCKER CATTLE 
Summary 
One thousand forty-six newly received steer and bull calves and 
yearlings (11 truck loads) averaging 215 kilograms were used in a study 
to determine the effect of the coccidiostats, lasalocid and 
decoquinate, on health and performance over a 28 day receiving period. 
All cattle had ad libitum access to prairie grass hay and were fed .9 
kg per day of a soybean meal-based pellet for the first 21 days and .45 
kg per day during days 22-28. The pelleted supplement contained no 
drugs, lasalocid (165 mg/kg feed), or decoquinate (110 mg/kg feed). 
Lasalocid or decoquinate did not influence the weight gains or health 
of stressed cattle with the data pooled across loads. However, the 
number of sick days per head and morbidity tended to be increased with 
the feeding of lasalocid (1.99 vs 1.65 days and 27 vs 22%). Some truck 
loads of cattle responded differently to the three supplements than 
other loads. In some loads, those cattle fed coccidiostats outgained 
and experienced less sickness than cattle fed the control supplement, 
whereas, in other loads those cattle fed the control diet performed 
better than those fed a coccidiostat. No clinical signs of coccidiosis 
were detected in any of the truck loads. It appeared that the origin 
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of the cattle, previous history of the cattle, and the degree of 
previous stress imposed on the cattle affected the response to the feed 
treatments. 
Introduction 
Coccidiosis is a common health problem among newly arrived stocker 
cattle in Oklahoma (Lusby, 1985). The disease causes economic losses 
due to increased morbidity and death loss, high labor and treatment 
costs, and reduced feed efficiencies and weight gains. Fox (1984) 
reviewed recent field data and concluded the following: 1) low level 
or subclinical coccidiosis caused serious economic losses and 
interfered with optimum performance, 2) the severity of the symptoms of 
coccidiosis was both affected by and contributed to stress, and 3) 
medication with a coccidiostat removed one of the stresses associated 
with cattle husbandry and helped reduce the severity of other diseases. 
The coccidiostat, decoquinate, has been reported to increase 
weight gains and feed efficiency and reduce morbidity and death loss in 
stocker steers and heifers (Hutcheson and Cummins, 1982; Fox, 1984; 
Barnes et al., 1984, 1985; Lusby et al., 1985). Other studies have 
reported that including decoquinate in the diet of newly received 
calves did not alter the performance or health status of calves (Prouty 
et al., 1981; Rust et al., 1981; Williams and Mahoney, 1984). This may 
reflect either reduced drug effectiveness, reduced incidence of 
coccidiosis, or less stress. 
In addition, the ionophore, lasalocid, when fed at sufficiently 
high levels is an effective coccidiostat for cattle (Horton, 1982). 
Also, feeding lasalocid to newly arrived stocker steers exhibiting no 
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signs of coccidiosis increased weight gains by 7.8% in one trial (Gill 
et a 1 • , 1982 b) • 
The objective of this research was to study the effect of 
lasalocid or decoquinate on the health and performance of newly arrived 
stocker cattle. 
Experimental Procedure 
This study was conducted as part of experiment one of the mass 
medication study (control vs long-acting oxytetracycline and sustained 
release sulfadimethoxine) reported in Chapter III of this manuscript. 
The experimental procedures of this study are described there (Hicks, 
1985a). 
Pooled data in this study were analyzed statistically using truck 
means with missing values calculated by standard equations given by 
Snedecor and Cochran (1967). Truck X feed treatment X medical 
treatment was used as the error term. 
Data on feed intake and gain to feed ratio were analyzed using 
pens as the experimental unit since feed records were kept on a pen 
basis. The initial models for these two criteria included truck, feed 
treatment, medical treatment, all two way interactions, and initial pen 
weight. Initial models were reduced when sources of variation had 
observed significance levels greater than .20. 
Results and Discussion 
Effects of lasalocid or decoquinate on daily gains, sick days, and 
morbidity across all cattle are presented in Table X. Gains averaged 
across all cattle (sick and never sick) in the 28 day day receiving 
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period were not affected by lasalocid or decoquinate. However, gains 
of those cattle that were never sick were reduced by 6.5% (P<.10) with 
the feeding of decoquinate (.72 vs .77 kg/head/day). The number of 
sick days per head tended to be increased with the feeding of lasalocid 
(1.99 vs 1.65 days). Morbidity also was slightly increased in cattle 
fed lasalocid (27 vs 22%). 
Effects of lasalocid or decoquinate on the performance and health 
of the sick cattle are reported in Table XI. Daily gains tended to be 
increased in cattle fed lasalocid (.49 vs .45 kg/head). Sick days 
tended to be decreased with the feeding of decoquinate (5.99 vs 6.19 
days/head). 
Data on feed intake and gain to feed ratio is presented in Table 
XII. Feed intake was slightly reduced with the feeding of decoquinate 
(6.34 vs 6.52 kg/head/day). Gain to feed ratio was not influenced by 
either lasalocid or decoquinate. 
Effects of lasalocid or decoquinate on weight gains, sick days, 
and morbidity in each truck load of cattle are presented in Table XIII 
(raw means). Results were inconsistent between truck loads. In some 
truck loads cattle fed lasalocid had faster gains than control cattle 
(1, 3, 6,8, and 9), whereas, in other loads cattle fed lasalocid had 
lower gains than control cattle (2, 7, and 11). Similar 
inconsistencies on the effect of lasalocid on morbidity were noted. 
Lasalocid tended to increase morbidity in five loads (1, 2, 4, 6, and 
7) and decrease it in four loads (3, 8, 9, and 10). The effects of 
decoquinate on weight gains and morbidity were also quite variable, 
tending to increase daily gains in three loads (7, 8, and 9) and 
decrease gains in seven loads (1, 2, 3, 5, 6, 10, and 11). Similar 
TABLE X 
EFFECT OF LASALOCID OR DECOQUINATE ON DAILY GAINS, SICK DAYS AND MORBIDITY IN STRESSED CATTLE 
Control Lasalocid Decoquinate 
Number of head 342 348 356 
Nllllber of head never sick 261 265 268 
Arrival weight, kg 214 216 217 
Daily gain, kg • 69 • 68 • 65 
Daily gain of 
.77b .77b • 72a head never sick, kg 
Sick days 1. 65 1.99 1. 63 
Morbidity, % 22.0 27.0 24.0 
a, Means with different superscripts differ (P<.10). 
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TABLE XI 
EFFECT OF LASALOCI D OR DECOQUINATE ON DAILY 
GAINS AND SICK DAYS IN SICK CATTLE 
Number of head 
Daily gain, kg 
Sick days 
Contro 1 
81 
.45 
6.19 
TABLE XII 
Lasal oci d 
83 
• 49 
6.11 
EFFECT OF LASALOCID OR DECOQUINATE ON FEED 
INTAKE AND GAIN TO FEED RATIO 
Control Lasal oci d 
Number of pens 17 17 
* Feed intake, kg 6.52 6.51 
* kg gain/kg feed .112 .114 
* Expressed as LSMEANS. 
Decoquinate 
88 
.46 
5.99 
Decoq uinate 
17 
6.34 
.113 
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variability in morbidity was observed. Morbidity was higher in those 
cattle fed decoquinate than in the control cattle in five loads (1, 3, 
5, 6, and 11) but lower in four loads (4, 7, 9, and 10). 
In this study, the feeding of the coccidiostats, lasalocid or 
decoquinate, did not affect the health or performance of newly 
received, stressed cattle. No clinical signs of coccidiosis were 
detected in any of the cattle during this study. If cattle are not 
experiencing coccidiosis, a coccidiostat such as decoquinate would have 
no benefit. Lasalocid, an ionophore, might still improve performance 
of the cattle (Gill et al., 1982b). 
Results of this study suggest that response of newly received 
cattle to a coccidiostat may depend on the origin of the cattle and the 
degree of previous stress imposed on the cattle. Barnes et al. (1984) 
suggested that season of the year also might be another factor 
affecting the response of cattle to coccidiostats. 
The major finding from this study was that in conducting research 
with newly received cattle (animal health studies) that each truck load 
of cattle should be considered as a separate trial. Factors such as 
origin of the cattle, medication history, time in transit, and degree 
and type of previous stress probably influence the response of cattle 
to experimental treatments. Thus, one load of cattle may respond 
differently to treatments than another load. Conclusions drawn from 
animal health research using one load of cattle can not be applied to 
cattle in general since the next load of cattle may respond 
differently. 
72 
TABLE XI I I 
EFFECT OF LASALOCID OR DECOQUINATE ON DAILY GAINS, 
SICK DAYS AND MORBIDITY IN STRESSED CATTLE--
RAW MEANS FOR EACH LOAD 
Number Daily Sick % 
of Head Gain, kg Days Morbidity 
Trial 1 
Truck 1 
Control 34 1.09 1.3 23.5 
Lasal oci d 33 1.13 3.3 48.5 
Decoquinate 34 1. 09 2.1 48.1 
Trial 2 
Truck 2 
Control 42 .96 .6 11.9 
Lasal oci d 32 .87 1.3 18.8 
Decoquinate 21 • 79 .6 14.3 
Truck 3 
Control 20 • 68 1.2 25.0 
Lasal oci d 29 • 76 .3 10.3 
Decoquinate 42 .56 1.4 26.2 
Trial 3 
Truck 4 
Control 35 1.02 1.3 25.7 
Lasal oci d 23 .96 2.5 47.8 
Decoquinate 46 1. 02 1.3 21.7 
Truck 5 
Control 22 • 81 0 0 
Lasal oci d 44 .80 0 0 
Decoquinate 22 .72 .6 13.6 
Trial 4 
Truck 6 
Control 21 • 70 1.3 19.0 
Lasal oci d 41 • 73 1.7 26.8 
Decoq uinate 31 • 65 1.0 25.8 
Truck 7 
Control 44 .63 4.0 40.9 
Lasal oci d 22 • 55 5.9 68.2 
Decoquinate 33 • 73 2.2 36.4 
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TABLE XIII (Cant inued) 
Number Daily Sick % 
of Head Gain, kg Days Morbidity 
Trial 5 
Truck 8 
Control 20 • 34 2.0 30.0 
Lasalocid 20 • 44 .8 15.0 
Decoquinate 39 • 45 2.0 30.8 
Truck 9 
Control 36 • 27 4.9 66.7 
Lasal oci d 36 • 31 3.4 50.0 
Decoq u in ate 18 .40 4.5 61.1 
Trial 6 
Truck 10 
Control 45 • 55 .2 4.4 
Lasal oci d 22 • 55 0 0 
Decoquinate 34 • 46 0 0 
Truck 11 
Control 23 .57 0 0 
Lasal oci d 46 • 55 0 0 
Decoquinate 36 .49 .3 5.5 
CHAPTER V 
THE EFFECT OF INTERFERON ON HEALTH AND 
PERFORMANCE OF NEWLY ARRIVED 
STOCKER CATTLE 
Surrmary 
Three hundred thirty-two newly received steer and bull calves and 
yearlings averaging 223 kilograms were divided into two groups. One 
hundred seventeen head received routine processing upon arrival and 215 
head received routine processing plus intranasal administration of 
recombinant leukocyte hybrid A/D interferon (INF). Administration of 
interferon reduced (P<.05) morbidity by 20.6% (39.7% for INF cattle vs 
50.0% for controls). Sick days were reduced (P<.01) by 33.3% with INF 
treatment (3.2 vs 4.8 days/head) and repulls were decreased by 39.5% 
(11.8 vs 19.5%). Cattle treated with INF tended to gain faster (11.4%) 
than control cattle (.78 vs .70 kg/head/day), consumed less fed (P<.05) 
and had 16.3% higher (P<.05) gain to feed ratios (.107 vs .092 kg 
gain/ kg feed). 
Introduction 
Interferon is a small protein produced or released by animal cells 
in response to invasion by viral or certain nonviral stimuli which 
indirectly protects other cells against viral damage by stimulating the 
production of new antiviral polypeptide or protein (Rosenquist, 1973). 
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Interferon is believed to play an important role in the recovery of 
host animals from viral infections (Isaacs, 1963; Baronet al., 1966) 
which is independent of the body•s specific immune mechanisms 
(Rosenquist and Loan, 1969). 
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Viruses of almost every major viral group have been shown to 
induce and be affected by interferon though some are more efficient 
stimulators of interferon production or are more sensitive to its 
actions than others (Rosenquist, 1973). Those viruses most commonly 
associated with the Bovine Respiratory Disease (BRD) complex that have 
been shown to induce interferon production are infectious bovine 
rhinotracheitis (IBR) and parainfluenza-3 (Rosenquist and Loan, 1967, 
1969). Interferon has been shown to protect against heterologous 
respiratory tract viral infections (Todd et al., 1972; Cummins and 
Rosenquist, 1980, 1982a, 1982b). Cummins and Hutcheson (1983) reported 
that calves orally administered with interferon once daily on the day 
of and for two days subsequent to IBR virus inoculation gained faster 
than control calves and calves receiving interferon intravenously or 
intranasally. 
The objective of this research was to study the effect of 
intranasal administration of recombinant leukocyte hybrid A/D 
interferon on the health and performance of newly arrived stocker 
cattle. 
Experimental Procedure 
Four truck loads (trials) of cattle were purchased by order buyers 
from auction markets in Alabama, Kentucky, Texas, and Oklahoma and 
shipped to Pawhuska, Oklahoma. The arrival date and weight, origin, 
number of head, and in-transit shrink for each load is summarized in 
Table XIV. Newly received cattle were weighed individually as 
unloaded, ear tagged and treated with Lysoff®1• Following weighing 
and tagging cattle were placed in pens of 20 to 25 animals each 
depending on the number of cattle received. Cattle were randomly 
assigned by pen to one of the following two treatments: controls 
(received no interferon) or intranasal administration of recombinant 
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leukocyte hybrid A/D interferon at one million units per kg of body 
weight. Water and native bluestem grass hay were provided free choice. 
The morning following arrival, the cattle were processed as follows: 
1. Body temperature and time were recorded. 
2. Cattle were vaccinated with IBR-PI 3 (MLV) IM, Leptospira 
pomona bacterin and Clostridia chauvoei, septicum, novyi, and 
sordellii bacterin. 
3. Cattle in interferon treatment groups received intranasal 
administration of interferon. 
4. Cattle with odd-numbered ear tags were dewormed with 
ivermectin 2 (200mcg/kg) and those cattle with even-numbered ear tags 
served as controls as part of a deworming trial superimposed on this 
study. 
5. Cattle were started on antibiotic treatment if clinical signs 
of illness were detected or if body temperature exceeded 40°C except 
for one-third of the cattle which received no treatment if they became 
sick. 
1cutter Laboratories, Shawnee Mission, KS 66201 
2rvomec®, MSD Agvet, Rahway, NJ 07065 
Trial 
1 
2 
3 
4 
TABLE XIV 
ORIGIN, ARRIVAL DATE, NUMBER OF HEAD, ARRIVAL WEIGHT 
AND IN-TRANSIT SHRINK FOR EACH LOAD OF 
CATTLE--INTERFERON STUDY 
Arrival Number Arrival 
Origin Date of Heada Wt., kg 
AL 10-12-84 98 217 
KY 11-14-84 91 230 
TX 12-20-84 93 216 
OK & TX 2-15-85 87 226 
% 
Shrink 
6.9 
5.0 
6.9 
7.4 
a19 and 18 head from trials 1 and 2, respectively, used in other 
experiments (not interferon). 
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6. For sick cattle, a hospital card was initiated and the calf 
was placed in a hospital pen. 
As soon as cattle were placed in their pens, they had ad libitum 
access to bluestem hay and were offered a pelleted feed supplement 
(Table II - with lasalocid) at a rate of .9 kg/head/day for the first 
21 days and .45 kg/head/day during days 22-28. 
After processing, cattle were checked twice daily for signs of 
illness. If an animal was suspected to be sick, it was moved to the 
processing area where its body temperature was determined and a 
severity of illness score (slight, moderate, or severe) was assigned. 
I~ the body temperature exceeded 40°C the animal was considered sick. 
Animals could also be classified as sick based on clinical signs. 
Medical treatment for sick animals was determined by the ear tag 
number which was applied at random on arrival. Treatment schedules 
were (A) no treatment (negative controls), (B) a sequence of 
antimicrobial drugs listed in Table XV, or (C) an experimental 
potentiated sulfa (R05-00373) substituted for Treatment 1 in Table 
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XV. Cattle treated by schedules B and C were initially treated with 
the first drug in the sequence. If body temperature dropped by 1.1°C 
or to less than 40°C, or clinical signs were improved within 24 hours, 
the drug was continued for two more days. If no improvement was 
apparent within 24 hours, the next drug in the sequence was applied and 
the procedure repeated until improvement was detected. Cattle treated 
by schedule C received R05-0037 boluses orally (66 mg/kg on day one and 
33 mg/kg/day thereafter). 
3Primor®, Hoffmann-LaRoche, Inc., Nutley, NJ 07110. 
TABLE XV 
SEQUENCE OF DRUGS USED FOR TREATMENT OF BRD--
1984-1985 EXPERIMENTS 
Treatment No 1: OXYTETRACYCLINE (Biomycin-C®) subcutaneously -11 mg/kg. 
Treatment No 2: a 
Treatment No 3:a 
Treatment No 4:a 
Treatment No 5:a 
Plus 
SULFAMETHAZINE BOLUSES (15 gm) 1 bolus/68 kg 
on day 1. One bolus/136 kg on subsequent days 
ERYTHROMYCIN (Gallamycin®) deep in the 
muscles - 22 mg/kg 
SPECTINOMYCIN (Spectam®) - 11 mg/kg. 
Procaine Penicillin G subcutaneous 1 y - 66,000 I U/ kg. 
TYLAN 200 - 22 mg/kg. 
aSome of the antimicrobial drugs used in this study were used for 
extra-label purpose or at extra-label dosages and require a 
veterinarian-client-patient relationship before use. 
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At the end of the 28 day trial, the cattle were held overnight 
without feed or water, weighed the following morning and, as necessary, 
cattle were castrated and horns were tipped. Cattle were then returned 
to the owner. 
Least squares analysis of variance was performed on data for all 
response criteria using the General Linear Model of the Statistical 
Analysis System (SAS). The initial models across all cattle for weight 
gains, sick days, morbidity, and mortality included trial (truck load), 
medical treatment (INF), ivermectin, all two way interactions, and 
initial weight. These same models were also used in analyzing the data 
with all the sick head pulled at processing excluded. The initial 
models for weight gains, sick days, repulls, and response to first drug 
treatment in the sick head included the same sources of variation with 
the addition of sick treatment. Feed intakes and gain to feed ratios 
were analyzed using pens as the experimental unit since feed records 
were kept on a pen basis. The initial models for these two criteria 
included medical treatment, trial, and initial pen weight. All models 
were reduced when sources of variation had observed significance levels 
greater than .20. However, medical treatment remained in all models 
since it was the source of variation being studied. 
Results and Discussion 
Effects of interferon on weight gains, sick days, morbidity, and 
mortality across all cattle are presented in Table XVI. Average daily 
gains during the 28 day receiving period were .78 kg/day for cattle 
treated with INF and .70 kg/day for the control cattle. The average 
number of sick pen days per head was significantly decreased (P<.Ol) 
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with INF treatment from 4.8 to 3.2 days. Morbidity was high in both 
groups, but was lower (P<.Q5) in the INF group (39.7 vs 50.0%). Death 
loss was decreased in the INF treated group (3.1 vs 4.6%). The death 
loss percentage among cattle that were treated when they became ill by 
treatment schedule B or C was 1.6% in the control cattle and 0% in the 
cattle treated with INF. 
Average daily gains of the cattle that were never sick were 1.0 
and .90 kg/head/day for control cattle and cattle treated with INF, 
respectively. Apparently the increased gains observed in all cattle 
treated with INF were due to reduced sickness. It appears that 
interferon does not increase weight gains of cattle that never become 
sick. 
Effects of interferon on the health and performance of the sick 
cattle are reported in Table XVII. Daily gains of the sick cattle 
were increased by 30.4% with INF administration (.61 vs .46 kg/head). 
The number of treatment days per sick head tended to be lower in the 
INF treated group (9.1 vs 9.7 days) and the number of repulls also 
tended to be lower in this group (11.8 vs 19.5%). Cattle treated with 
INF tended to responded more favorably to first drug treatment (49.3 vs 
43.5%). 
Feed intakes and gain to feed ratios are presented in Table XVIII. 
Interferon treatment reduced feed intake (P<.05) from 7.93 to 7.37 kg 
per head per day. This 7.1% reduction in feed intake combined with the 
11.4% increase in daily gains with INF treatment resulted in an 
improvement (P<.05) in gain to feed ratio of 16.3% (.107 vs .092 kg 
gain/kg feed). 
Interferon should begin affecting the animal •s non-immune defenses 
TABLE XVI 
EFFECT OF INTERFERON ON DAILY GAINS, SICK DAYS, 
MORBIDITY AND MORTALITY IN STRESSED CATTLE 
Number of head 
Number of head never sick 
Arrival weight, kg 
* Average daily gain, kg 
* Daily gain of head never sick, kg 
. * S1ck days 
* Morbidity, % 
o~* Total Mortality, ~ 
Mortality excluding treatment* 
schedule A cattle, % 
Expressed as LSMEANS. a,~eans with different superscripts c,(.~eans with different superscripts 
e, Means with different superscripts 
Controls 
117 
59 
223 
• 70 
1.00 
4.8b 
so.od 
4.6 
differ (P<.01). 
differ (P<.05). 
differ (P<.lO). 
Interferon 
215 
126 
222 
• 78 
.90 
3.2a 
39. 7c 
3.1 
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TABLE XVI I 
EFFECT OF INTERFERON ON DAILY GAINS, SICK DAYS, REPULLS 
AND RESPONSE TO FIRST TREATMENT IN SICK CATTLE 
Number of head 
* Average daily gain, kg 
* Sick days 
* Repull s, % 
Controls 
58 
Response to first treatment, %* 
• 46 
9. 7 
19.5 
43.5 
* Expressed as LSMEANS. 
TABLE XVIII 
EFFECT OF INTERFERON ON FEED INTAKE 
AND GAIN TO FEED RATIO 
N tJTiber of pens 
Feed intake, kg* 
kg gain/kg feed* 
* 
Controls 
Expressed as LSMEANS. 
abMeans with different superscripts differ, (P<.05). 
Interferon 
89 
• 60 
9.1 
11.8 
49.3 
Interferon 
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approximately 24 hours after administration (Fulton, 1985). Hence, the 
data also was analyzed with those cattle pulled as sick at processing 
excluded from the model (15 control head and 19 INF head) since INF 
could not have affected the initial sickness in these cattle. Effects 
of interferon on weight gains, sick days, morbidity, and mortality with 
these head excluded are summarized in Table XIX. Average daily gains 
tended to be higher in the INF treated group (.79 vs .74 kg/day). 
Cattle treated with INF had fewer sick days (P<.01, 2.5 vs 4.0 
days/head) and lower morbidity (35.4 vs 43.8%). Mortality was higher 
in the cattle treated with INF (3.1 vs 2.4%). 
Effects of interferon on the health and performance of sick cattle 
with those head pulled at processing excluded are presented in Table 
XX. Cattle treated with INF tended to have higher weight gains (.62 vs 
.49 kg/head/day), fewer sick days (8.4 vs 9.3 days/head), and fewer 
repulls (12.3 vs 21.9%) than control cattle. Response to first drug 
treatment was also higher in the INF treated group (56.4 vs 51.7%). 
Under the conditions of this study health and performance of newly 
arrived cattle tended to be improved by treatment with intranasal 
recombinant leukocyte hybrid A/0 interferon. Interferon holds promise 
as a means of reducing sickness and improving health in stressed 
stocker cattle. However, further studies need to be conducted with INF 
before definite conclusions concerning its effects and economics can be 
made. 
TABLE XIX 
EFFECT OF INTERFERON ON DAILY GAINS, SICK DAYS, MORBIDITY 
AND MORTALITY IN STRESSED CATTLE WITH SICK HEAD 
PULLED AT PROCESSING EXCLUDED 
Number of head 
Arrival weight, kg 
* Average daily gain, kg 
* Sick days 
* Morbidity, % 
* Total Mortality, % 
* Mortality excluding treatment 
schedule A cattle, % 
* 
Controls 
102 
223 
• 74 
4.0b 
43.8 
2.4 
1.0 
bExpressed as LSMEANS. 
a, Means with different superscripts differ (P<.01). 
TABLE XX 
Interferon 
194 
223 
• 79 
2.5a 
35.4 
3.1 
0 
EFFECT OF INTERFERON ON DAILY GAINS, SICK DAYS, REPULLS 
AND RESPONSE TO FIRST TREATMENT IN SICK CATTLE 
WITH HEAD PULLED AT PROCESSING EXCLUDED 
Number of head 
* Average daily gain, kg 
* Sick days 
* Repulls, % 
Response to first treatment, %* 
* Expressed as LSMEANS. 
Controls 
43 
.49 
9.3 
21.9 
51.7 
Interferon 
68 
• 62 
8.4 
12.3 
56.4 
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CHAPTER VI 
THE EFFECT OF RESPIRATORY SYNCYTIAL VIRUS 
VACCINE ON HEALTH AND PERFORMANCE OF 
NEWLY ARRIVED STOCKER CATTLE 
Summary 
One-hundred forty three newly received steer and bull calves and 
yearlings averaging 214 kilograms were divided into two groups. 
Eighty-four head received routine processing upon arrival and 59 head 
received routine processing plus respiratory syncytial virus (RSV) 
vaccine. Vaccinat1on with RSV vaccine decreased daily gain (.73 vs .61 
kg/head). Morbidity was higher for the RSV vaccine group than for the 
control cattle (64.8 vs 47.3%). Sick days were higher in the RSV 
vaccine group (6.4 vs 4.5 days/head) and death loss was higher in the 
vaccinated group also (13.6 vs 2.4%). In this study, the use of RSV 
vaccine was detrimental to the health and performance of newly received 
stressed cattle during a 28 day receiving period. 
Introduction 
Respiratory syncytial virus (RSV) has been detected in respiratory 
infections of cattle with severe clinical and pathological features 
(Rosenquist, 1974) and recent work suggested that RSV may be associated 
with the Acute Respiratory Distress Syndrome of calves (Frey, 1983). 
Antibody surveys have shown that the virus is common in cattle 
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populations (Rosenquist, 1983). A modified live virus vaccine was 
recently introduced onto the market for use in cattle. The objective 
of this research was to study the effect of RSV vaccine on the health 
and performance of newly arrived stocker and feeder cattle. 
Experimental Procedure 
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Three truck loads (three trials) of cattle were purchased by order 
buyers from auction markets in Alabama, Kentucky, and Tennessee and 
shipped to Pawhuska, Oklahoma. The arrival date and weight, origin, 
number of head, and in-transit shrink for each load is summarized in 
Table XXI. Trials one and two had cattle which were part of the 
interferon study. Newly received cattle were handled and processed in 
the same manner as described for the interferon study, Chapter V of 
this manuscript (Hicks, 1985b), except that the cattle were randomly 
assigned by pen to one of the following two treatments: unvaccinated 
controls or intramuscular vaccination with respiratory syncytial virus 
vaccine1• After processing, cattle were checked twice daily for 
signs of illness and treated as described in the interferon experiment 
(Hicks, 1985b). 
Least squares analysis of variance was performed on data for all 
response criteria using the General Linear Model of the Statistical 
Analysis System (SAS). The initial models across all cattle for weight 
gains, sick days, morbidity, and mortality included trial (truck load), 
medical treatment (RSV), ivermectin, all two way interactions, and 
1Bovine Respiratory Syncytial Vaccine (serial number 57), Norden 
Laboratories, Lincoln, NE. 
Trial 
1 
2 
3 
TABLE XX I 
ORIGIN, ARRIVAL DATE, NUMBER OF HEAD, ARRIVAL WEIGHT 
AND IN-TRANSIT SHRINK FOR EACH LOAD OF 
CATTLE--RSV VACCINE STUDY 
Arrival Number Arrival 
Origin Date of Heada Wt., kg 
TN 8-18-84 94 220 
AL 10-12-84 98 217 
KY 11-14-84 91 230 
a25, 60 and 55 head from trials 1, 2 and 3, respectively used 
experiments (not RSV). 
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% 
Shrink 
8.3 
6.9 
5.0 
in other 
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initial weight. The initial models for weight gains, sick days, 
repulls, and response to ftrst drug treatment in the sick cattle 
included the same sources of variation with the addition of sick 
treatment. Feed intake and gain to feed ratio were analyzed using pens 
as the experimental unit since feed records were kept on a pen basis. 
The initial models for these two criteria included medical treatment, 
trial, and initial weight. All models were reduced when sources of 
variation had observed significance levels greater than .20. However, 
medical treatment remained in all models since it was the source of 
variation being studied. 
Results and Discussion 
Effects of RSV vaccine on weight gains, sick days, morbidity, and 
mortality are shown in Table XXII. Average daily gains during the 28 
day receiving period were .73 kg/day for the control cattle and .61 
kg/day for those cattle vaccinated with RSV vaccine. However, cattle 
vaccinated with RSV vaccine that were never sick gained faster {P<.05) 
than control cattle {1.25 vs 1.09 kg/head/day). The average number of 
sick days per head was increased (P<.10) with RSV vaccine from 4.5 to 
6.4 days. Morbidity was high in both groups, but greater (P<.05) in 
the group vaccinated with RSV vaccine (64.8 vs 47.3%). Death loss was 
increased (P<.01) in the RSV vaccine group (13.6 vs 2.4%). The death 
loss percentage among cattle that were treated when they became ill by 
treatment schedule B or C was 5.3% in the RSV vaccinated group and 0% 
in the unvaccinated controls. 
Effects of RSV vaccine on the health and performance of the sick 
cattle are shown in Table XXIII. Daily gains of the sick cattle were 
decreased by 49% by RSV vaccination (.25 vs .49 kg/head). The number 
of treatment days per sick head was increased from 9.3 days to 11.4 
days with RSV vaccine. Number of repulls were higher in the RSV 
vaccinated group (38.4 vs 23.5%). Cattle vaccinated with RSV vaccine 
also tended to have a lower response to first drug treatment (42.1 vs 
51.9%). 
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Feed intakes and gain to feed ratios are presented in Table XXIV. 
Feed intake was increased in the RSV vaccine group. However, since 
weight gains were lower for RSV cattle, gain to feed ratio was 
decreased (P<.05) by RSV vaccination. 
Under the conditions of this study, health and performance of 
newly arrived cattle were impaired by treatment with respiratory 
syncytial virus vaccine. This vaccine offered no economic advantage in 
processing of stressed cattle in this study. 
TABLE XXII 
EFFECT OF RSV VACCINE ON DAILY GAINS, SICK DAYS, 
MORBIDITY AND MORTALITY IN STRESSED CATTLE 
Number of head 
Number of head never sick 
Arrival weight, kg 
* Average daily gain, kg 
* Daily gain of head never sick, kg 
* Sick days 
Morbidity, % * 
%* Total Mortality, 
* Mortality excluding treatment 
schedule A cattle, % 
* 
Controls 
84 
44 
213 
• 73 
1. 09c 
4.5a 
47.3c 
2.4e 
bExpressed as LSMEANS. a, 0~eans with different superscripts differ (P<.10). 
c,fMeans with different superscripts differ (P<.OS). 
e, Means with different superscripts differ (P<.01). 
RSV Vaccine 
59 
21 
215 
• 61 
1. 25d 
6.4b 
64.8d 
13.6f 
s./ 
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TABLE XXIII 
EFFECT OF RSV VACCINE ON DAILY GAINS, SICK DAYS, REPULLS 
AND RESPONSE TO FIRST TREATMENT IN SICK CATTLE 
Number of head 
. kg* Average daily ga1n, 
Sick days* 
* Repull s, %
Controls 
40 
Response to first treatment, %* 
23.5 
51.9 
* Expressed as LSMEANS. 
a,bMeans with different superscripts differ (P<.lO). 
TABLE XXIV 
RSV Vaccine 
38 
.25a 
11.4b 
38.4 
42.1 
EFFECTS OF RSV VACCINE ON FEED INTAKE 
AND GAIN TO FEED RATIO 
NlJJiber of pens 
Feed intake, kg* 
kg gain/kg feed* 
* 
Controls 
4 
7.20 
.105b 
Expressed as LSMEANS. 
a,9Means with different superscripts differ (P<.05). 
RSV Vaccine 
3 
8.26 
• 072a 
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CHAPTER VII 
THE EFFECT OF LIVE PASTEURELLA HEMOLYTICA 
VACCINE ON HEALTH AND PERFORMANCE OF 
NEWLY ARRIVED STOCKER CATTLE 
Summary 
Five hundred four newly received steer and bull calves and 
yearlings averaging 241 kilograms were divided into two groups. Two 
hundred fifty-six head received routine processing upon arrival and 248 
head received routine processing plus live Pasteurella hemolytica 
(PH) vaccine. Vaccination with PH vaccine decreased (P<.10) the 
incidence of sickness by 18% (33.1% for PH cattle vs 40.4% for 
controls). Sick days also were lower in the PH vaccine group (2.2 vs 
2. 7 days/head) and death loss was decreased (P<.10) by vaccination from 
1.2% to 0%. Daily gains were not affected by vaccination with PH 
vaccine in this study. 
Introduction 
Pasteurella hemolytica has been known to be associated with 
the shipping fever-bovine respiratory disease (BRD) complex since the 
1950's (Carter, 1954; Gale and King, 1961). More recently it was 
isolated from the pneumonic lungs of feedlot cattle (Hjerpe and Routen, 
1976; Martinet al., 1980). It is the most commonly isolated bacterial 
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pathogen from the acutely affected bovine lung (Brown, 1979; Frank and 
Smith, 1983). 
Over the past 50 years much research as been conducted with 
Pasteurella bacterins in an effort to control BRO. Wilkie (1980) 
reviewed studies on the biological control of BRD and concluded that 
Pasteurella bacterins have no obvious use in control of the disease. 
Field trials have shown that the bacterins increase morbidity and 
mortality and decrease weight gains in feedlot cattle (Woods, et al., 
1976; Martinet al., 1980; Amstutz et al., 1981). Recent research with 
live Pasteurella hemolytica vaccine has shown more promising 
results (Hutcheson et al., 1983; Purdy et al., 1983). Smith (1983) 
reported results of field trials in which PH vaccine was used in 
commercial cattle, preconditioned cattle, and feedlot cattle. It 
reduced morbidity by 89%, 77%, and 44%, respectively. 
The objective of this research was to study the effect of PH 
vaccine on the health and performance of newly arrived stocker and 
feeder cattle. 
Experimental Procedure 
Six truck loads (trials) of cattle were purchased by order buye~s 
from auction markets in Georgia, Kansas, Mississippi, Oklahoma, 
Tennessee, and Texas and shipped to Pawhuska, Oklahoma. The arrival 
date and weight, origin, number of head, and in-transit shrink for each 
load is summarized in Table XXV. Newly received cattle were weighed 
individually off the truck, ear tagged, and treated with Lysoff•1• 
1cutter Laboratories, Shawnee Mission, KS 66201 
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TABLE XXV 
ORIGIN, ARRIVAL DATE, NUMBER OF HEAD, ARRIVAL WEIGHT 
AND IN-TRANSIT SHRINK FOR EACH LOAD OF 
CATTLE--PH VACCINE STUDY 
Arr iva 1 Number Arrival % Trial Origin Date of Head Wt., kg Shrink 
1 TN 9-30-84 80 250 5.8 
2 GA 11-18-84 77 245 9.0 
3 MS 2-06-85 91 223 9.7 
4 TX & OK 2-12-85 92 236 3.4 
5 KS 3-10-85 88 250 4.8 
6 KS 3-18-85 76 251 5.1 
Following weighing and tagging, cattle were randomly divided into two 
groups and placed in separate pens. Water and native bluestem grass 
hay were provided free choice. The morning following arrival, the 
cattle were processed as follows: 
1. Body temperature and time were recorded. 
2. Cattle were vaccinated with IBR-PI 3 (MLV) IM, Leptospira 
pomona bacterin and Clostridia chauvoei, septicum, novyi, and 
sordellii bacterin. 
3. Cattle with even-numbered ear tags were vaccinated 
intradermally with live Pasteurella hemolytica vaccine2 
(.5ml/head) and those head with odd-numbered ear tags served as 
controls. 
4. Dewormed with ivermectin 3 (200mcg/kg). 
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5. Cattle were started on antibiotic treatment if clinical signs 
of illness were detected or if body temperature exceeded 40°C. 
6. For sick cattle, a hospital card was initiated and the calf 
was placed in a hospital pen. 
As soon as cattle were placed in their pens, they had ad libitum 
access to bluestem grass hay and were offered a pelleted feed 
supplement (Table XXVI) at a rate of .9 kg/head/day for the first 21 
days and .45 kg/head/day during days 22-28. In Trials 2 through 6, a 
vitamin E supplementation study was superimposed across this vaccine 
experiment. In each of these trials, one pen of cattle received a feed 
supplement containing vitamin E (1760 IU/kg) and the other pen received 
2PRECON-PH®, AGRI-BIO Corp., Gainsville, GA 30501 
3rvomec®, MSD Agvet, Rahway, NJ 07065 
TABLE XXVI 
COMPOSITION OF FEED SUPPLEMENTS--
PH VACCINE, VITAMIN E STUDY 
IFNa 
% As Fed 
Ingredient Control 
Soybean Meal 5-20-637 88.9 
Cottonseed Meal 5-01-621 5.0 
Salt 6-04-152 3.0 
Vitamin E - 220,000 IU/kgb 0 
Vitamin A - 30,000 IU/Gram • 22 
Premixc 
.18 
Dicalcium Phosphate 6-01-080 2. 75 
~International Feed Number. 
To provide 1760 IU vitamin E/kg. 
cTo provide 165 mg lasalocid/kg. 
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Vitamin E 
88.5 
5.0 
3.0 
.4 
• 22 
.11 
2. 75 
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supplement without addition of vitamin E (Table XXVI). Two hospital 
pens were maintained so that sick animals received their assigned feed 
while out of their home pen. 
After processing, cattle were checked twice daily for signs of 
illness as described in the experimental procedures for the interferon 
study, Chapter V of this manuscript (Hicks, 1985b). Medical treatment 
for sick animals was determined by the ear tag number. The same 
treatment schedules as outlined for the interferon study were followed 
except that no negative controls were included. Response to drug 
treatment was determined in the same manner as in the interferon study. 
At the end of the 28 day trial, the cattle were held overnight 
without feed or water, weighed the following morning and, when 
necessary, cattle were castrated and horns were tipped. Cattle were 
then returned to the owner. 
Least squares analysis of variance was performed on data for all 
response criteria using the General Linear Model of the Statistical 
Analysis System (SAS). The initial models across all cattle for weight 
gains, sick days, morbidity, and mortality included trial (truck load), 
feed treatment, PH vaccine, all two way interactions, and initial 
weight. These same models were also used in analyzing the data with 
all the sick head pulled at processing excluded. The initial models 
for weight gains, sick days, repulls, and response to first drug 
treatment in the sick cattle included the same sources of variation 
with the addition of sick treatment. All models were reduced when 
sources of variation had observed significance levels greater than .20. 
However, PH vaccine remained in all models since it was the source of 
variation being studied. 
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Results and Discussion 
Effects of PH vaccine ·on weight gains, sick days, morbidity, and 
mortality are shown in Table XXVII. Average daily gains during the 28 
day receiving period were not affected by the administration of PH 
vaccine. The number of sick days per head was reduced 18.5% in the 
vaccinated cattle (2.2 vs 2.7 days/head). Morbidity was reduced 
(P<.10) from 40.4% to 33.1% with PH vaccine (18.1% reduction) and death 
loss was lower (P<.10) in the PH vaccinated group. 
Effects of PH vaccine on the health and performance of the sick 
cattle are shown in Table XXVIII. Those sick cattle vaccinated with PH 
vaccine tended to gain slightly faster than those not vaccinated (.29 
vs .25 kg/head/day). The number of sick days per head and and the 
number of repulls tended to be greater in the vaccinated cattle than 
the nonvaccinated cattle (6.4 vs 6.2 days/head and 16.9 vs 14.4%). 
Trial two was the only trial in which PH vaccine appeared to increase 
repulls. The response of sick cattle to first drug treatment was 
greater in the vaccinated cattle (65.1 vs 52.9%). None of these 
differences proved significant. 
The data was also analyzed with those sick cattle pulled at time 
of processing excluded from the model (33 control head and 30 PH head) 
since it would take approximately 24 hours for the vaccine to have an 
affect on the cattle (Perino, 1985). Effects of PH vaccine on weight 
gains, sick days, morbidity, and mortality with these head excluded are 
presented in Table XXIX. The number of sick pen days per head was 
significantly reduced (P<.05) by 28.6% in the PH vaccinated cattle as 
compared to the nonvaccinated cattle (1.5 vs 2.1 days). This reduction 
TABLE XXVII 
EFFECT OF PH VACCINE ON DAILY GAINS, SICK DAYS, 
MORBIDITY AND MORTALITY IN STRESSED CATTLE 
Controls 
Number of head 256 
Number of head never sick 152 
Arrival weight, kg 241 
* Average daily gain, kg .42 
* Daily gain of head never sick, kg .55 
. * S1ck days 2.7 
Morbidity, %* 40.4b 
Mort a 1 ity, % 1. 2b 
* bExpressed as LSMEANS. 
a, Means with different superscripts differ (P<.10). 
TABLE XXVIII 
PH Vaccine 
248 
165 
240 
• 45 
.56 
2.2 
33.1a 
o.oa 
EFFECT OF PH VACCINE ON DAILY GAINS, SICK DAYS, REPULLS AND RESPONSE TO FIRST TREATMENT IN SICK CATTLE 
Number of head 
* Average daily gain, kg 
Sick days * 
* Repull s, % 
Response to first treatment, % 
* Expressed as LSMEANS. 
Controls 
104 
0 25 
6.2 
14.4 
52.9 
PH Vaccine 
83 
0 29 
6.4 
16.9 
65.1 
100 
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is greater than was observed with all cattle in the model. Morbidity 
was 22.8% lower in the PH vaccinated cattle than in the nonvaccinated 
cattle (25.1 vs 32.5%). 
Effects of PH vaccine on the health and performance of the sick 
cattle with those head pulled at processing excluded are reported in 
Table XXX. The results were quite similar to those observed with all 
sick head left in the model. The number of repulls for both vaccinated 
and nonvaccinated cattle was much lower with the data analyzed this way 
(8.6% for controls and 9.4% for PH cattle). It would appear that most 
of the cattle requiring retreatment for sickness were originally pulled 
at processing. 
Under the conditions of this study, health and performance of 
newly arrived cattle tended to be improved by treatment with live 
Pasteurella hemolytica vaccine. Vaccinated cattle experienced less 
sickness and required fewer treatments for BRD than nonvaccinated 
cattle. Smith (1983) in a trial with newly arrived feedlot calves 
noted greater benefits with PH vaccination (morbidity and treatment 
days reduced 44 and 40%, respectively) than were observed in this 
study. Purdy (1983) also reported that the vaccine tended to reduce 
mortality in 41 feeder calves. These data suggest that PH vaccine can 
improve the health of stressed cattle. 
TABLE XXIX 
EFFECT OF PH VACCINE ON DAILY GAINS, SICK DAYS, MORBIDITY 
AND MORTALITY IN STRESSED CATTLE WITH SICK HEAD 
PULLED AT PROCESSING EXCLUDED 
Number of head 
Arrival weight, kg 
* Average daily gain, kg 
* Sick days 
%* Morbidity, 
Mortality,% 
* 
Controls 
223 
234 
.45 
2.1b 
32.5d 
.45 
bExpressed as LSMEANS. 
a, Means with different superscripts differ (P<.05). 
c,dMeans with different superscripts differ (P<.10). 
TABLE XXX 
PH Vaccine 
218 
244 
0.0 
EFFECT OF PH VACCINE ON DAILY GAINS, SICK DAYS, REPULLS 
AND RESPONSE TO FIRST TREATMENT IN SICK CATTLE 
WITH HEAD PULLED AT PROCESSING EXCLUDED 
N l.ll1ber of head 
* Average daily gain, kg 
* Sick days 
* Repull s, % 
Response to first treatment, % 
* Expressed as LSMEANS. 
Contro 1 s 
71 
. 21 
5.9 
8.6 
52.6 
PH Vaccine 
53 
.25 
5.9 
9.4 
68.3 
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CHAPTER VIII 
THE EFFECT OF VITAMIN E SUPPLEMENTATION ON HEALTH 
AND PERFORMANCE OF NEWLY ARRIVED 
STOCKER CATTLE 
Summary 
Five hundred two newly received steer and bull calves and 
yearlings averaging 242 kilograms were used in a study to determine the 
effect of vitamin E supplementation on health and performance over a 28 
day receiving period. All cattle had ad libitum access to prairie hay 
and were fed .9 kg/day of a soybean meal-based pellet for the first 21 
days and .45 kg/day during days 22-28 with 252 of the cattle receiving 
vitamin E in their supplement (1760 IU/kg supplement). Cattle fed 
vitamin E gained .53 kg/day compared to .43 kg/day for control cattle 
(P<.01). Feed intake was not effected by vitamin E supplementation but 
cattle fed vitamin E had 28.6% higher gain to feed ratios than control 
cattle (.063 vs .049 kg gain/kg feed). The number of sick pen days per 
head was reduced by 15.6% (2.7 vs 3.2 days/head) and morbidity was 
reduced by 13.4% (37.5 vs 43.3%) with vitamin E supplementation. These 
data suggest that vitamin E supplementation improved the performance of 
newly received, stressed cattle. 
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Introduction 
Supplementing vitamin -E in pharmacal ogi cal doses in well balanced 
diets has been shown to increase humoral antibody production against a 
variety of particulate and soluble antigens in chickens, mice, turkeys, 
guinea pigs, and rabbits (Heinzerling et al., 1974a, 1974b; Tengerdy, 
1980). Studies also have shown that high levels of vitamin E may 
enhance the immune system of swine (Ellis and Vorhies, 1976), sheep 
(Tengerdy et al., 1983), and horses (Lewis et al., 1976). Smith et al. 
(1984) reported that vitamin E suppl em en tat ion reduced the incidence 
and duration of clinical mastitis in dairy cows. 
Little research has been conducted on the effects of vitamin Eon 
the health, immune response or performance of beef cattle. Early 
research showed vitamin E supplementation or inj~ction had no effect on 
weight gains of feedlot calves (Newland et al., 1966; Lyford and Colby, 
1967; Perry et al., 1968; Totusek et al., 1968). In contrast to these 
studies Lee et al. (1985) reported that vitamin E supplementation (400 
IU/head/day) of the receiving diet of stressed calves improved daily 
gains (P<.08) and feed efficiency (P<.02) by 5% and reduced morbidity 
and mortality by 8% and 50%, respectively. 
The vitamin E requirement of young calves is thought to be between 
15 and 60 IU/kg of dry diet (NRC, 1984). Normal diets are thought to 
supply adequate amounts of vitamin E for adult cattle. However, the 
nutrient needs of stressed cattle may be greater due to reduced feed 
and water intake and health problems. Therefor~, the objective of this 
research was to study the effect of dietary vitamin E supplementation 
(1760 IU/kg feed) on the health and performance of newly arrived 
stocker cattle. 
Experimental Procedure 
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Six truck loads (trials) of cattle were purchased by order buyers 
from auction markets in Georgia, Kansas, Mississippi, Oklahoma, and 
Texas and shipped to Pawhuska, Oklahoma. The arrival date and weight, 
origin, number of head, and in-transit shrink for each load is 
summarized in Table XXXI. This study was superimposed across the live 
Pasteurella hemolytica (PH) vaccine experiment (Chapter VII of this 
manuscript). For the experimental procedures of this study, refer to 
those given for the PH vaccine experiment (Hicks, 1985c). 
Least squares analysis of variance was performed on data for all 
response criteria using the General Linear Model of the Statistical 
Analysis System (SAS). The initial models across all cattle for weight 
gains, sick days, morbidity, and mortality included trial (truck load), 
feed treatment, PH vaccine, all two way interactions, and initial 
weight. These same models were also used in analyzing the data with 
all the sick head pulled at time of processing excluded. The initial 
models for weight gains, sick days, repulls, and response to first drug 
treatment in the sick cattle included the same sources of variation 
with the addition of sick treatment. Data on feed intake and gain to 
feed ratios were analyzed using pens as the experimental unit since 
feed records were kept on a pen basis. The initial models for these 
two criteria included trial, feed treatment, and initial pen weight. 
All models were reduced when sources of variation had observed 
significance levels greater than .20. However, feed treatment remained 
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TABLE XXXI 
ORIGIN, ARRIVAL DATE, NUMBER OF HEAD, ARRIVAL WEIGHT 
AND IN-TRANSIT SHRINK FOR EACH LOAD OF 
CATTLE--VITAMIN E STUDY 
Arrival Number Arrival % Trial Origin Date of Head Wt., kg Shrink 
1 GA 11-12-84 79 249 7.6 
2 GA 11-18-84 77 245 9.0 
3 MS 2-06-85 91 223 9.7 
4 TX & OK 2-12-85 92 236 3.4 
5 KS 3-10-85 88 250 4.8 
6 KS 3-18-85 76 251 5.1 
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in all models since it was the source of variation being studied. 
Results and Discussion 
Effects of vitamin E supplementation on weight gains, sick days, 
morbidity, and mortality are presented in Table XXXII. Gains in the 28 
day receiving period were significantly increased (P<.01) by vitamin E 
supplementation (.53 vs .43 kg/head/day). Daily gains of those cattle 
that were never sick were .61 and .67 kg/head/day for control cattle 
and cattle fed vitamin E, respectively. The number of sick pen days 
per head tended to be lower for the cattle fed supplemental vitamin E 
than for the control cattle (2.7 vs 3.2 days). Morbidity was also 
lower in these cattle (37.5 vs 43.3%). Death loss was 1.6% in the 
control cattle and 1.2% in the vitamin E cattle. 
Effects of vitamin E supplementation on the health and performance 
of the sick cattle are reported in Table XXXIII. Those sick cattle fed 
vitamin E gained .32 kg/day compared to .26 kg/day for sick control 
cattle. The number of treatment days per head tended to be lower in 
the vitamin E group (6.6 vs 7.0 days). However, the number of repulls 
was greater for the vitamin E cattle than for the control cattle (17.8 
vs 13.3%). The response to first drug treatment was similar for both 
treatments (61.5% and 58.8% for vitamin E and controls, respectively). 
Feed intakes and gain to feed ratios are reported in Table XXXIV. 
Vitamin E supplementation did not affect feed intake (8.00 vs 7.99 
kg/head/day for vitamin E and control, respectively). However, due to 
the 23.3% increase in daily gains, feed to gain ratio was increased 
from .049 to .063 kg gain/kg feed. 
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Effects of vitamin E supplementation on the health and the 
performance of cattle with those sick head pulled at time of processing 
excluded from the analysis are presented in Tables XXXV and XXXVI. 
Excluding these head from the analysis did not change the 
interpretation of results. With the data analyzed in this manner, 
cattle fed vitamin E gained 22.2% faster than control cattle (P<.05, 
.55 vs .45 kg/head/day). Vitamin E supplementation reduced morbidity by 
11.7% (30.9 vs 35.0%) and sick days by 12.5% (2.1 vs 2.4 days/head). 
In the sick cattle, vitamin E supplementation tended to increase gains 
and reduce sick days. 
Under the conditions of this study, vitamin E supplementation 
(1760 IU/kg supplement or 1600 IU/head/day) significantly increased 
weight gains and tended to reduce sickness in newly received, stressed 
stocker cattle. These results are consistent with those reported by 
Lee et al. (1985). These studies suggest that the vitamin E 
requirement of stressed cattle is higher than the 15 to 60 IU/kg of dry 
diet that is suggested by NRC (1984) for young calves. More studies 
need to be conducted in stressed cattle with different levels of the 
vitamin to determine its requirement for such cattle. 
TABLE XXXI I 
EFFECT OF VITAM!~ E SUPPLEMENTATION ON DAILY GAINS, 
SICK DAYS, MORBIDITY AND MORTALITY 
IN STRESSED CATTLE 
Controls Vitamin 
Number of head 252 250 
Number of head never sick 146 158 
Arrival weight, kg 240 244 
Average daily gain, kg * .43a .53b 
Daily gain of head never sick, kg * • 61 a .67b 
Sick days * 3.2 2.7 
Morbidity, %* 43.3 37.5 
Mortality, % 1.8 1.6 
* bExpressed as LSMEANS. 
a, Means with different superscripts differ (P<. 01). 
TABLE XXXIII 
EFFECT OF VITAMIN E SUPPLEMENTATION ON DAILY GAINS, 
SICK DAYS, REPULLS AND RESPONSE TO FIRST 
TREATMENT IN SICK CATTLE 
E 
Controls Vitamin E 
Number of head 
* Average daily gain, kg 
. * S1ck days 
* Repulls, % 
Response to first treatment, % 
* Expressed as LSMEANS. 
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.26 
7.0 
13.3 
58.8 
92 
• 32 
6.6 
17.8 
61.5 
109 
TABLE XXXIV 
EFFECT OF VITAMIN E SUPPLEMENTATION ON FEED 
INTAKE AND GAIN TO FEED RATIO 
Number of pens 
Feed intake, kg *. 
. * kg ga1n/kg feed 
* Expressed as LSMEANS. 
Controls 
6 
8.00 
. 049 
TABLE XXXV -
Vitamin E 
6 
7.99 
.063 
EFFECT OF VITAMIN E SUPPLEMENTATION ON DAILY GAINS, SICK 
DAYS, MORBIDITY AND MORTALITY IN STRESSED CATTLE 
WITH SICK HEAD PULLED AT PROCESSING EXCLUDED 
Number of head 
Arrival weight, kg 
* Average daily gain, kg 
* Sick days 
b %* Mor idity, 
Mortality, % 
* 
Controls 
216 
240 
2.4 
35.0 
.93 
bExpressed as LSMEANS. 
a, Means with different superscripts differ (P<.OS). 
Vitamin E 
222 
245 
• 55b 
2.1 
30.9 
• 45 
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TABLE XXXVI 
EFFECT OF VITAMIN E SUPPLEMENTATION ON DAILY GAINS, SICK 
DAYS, REPULLS AND RESPONSE TO FIRST TREATMENT IN SICK 
CATTLE WITH HEAD PULLED AT PROCESSING EXCLUDED 
Controls Vitamin E 
Number of head 68 63 
Average daily gain, kg * • 20 • 30 
Sick days * 6.6 6.2 
Repull s, % 8.2 9.5 
Response to first treatment, %* 62.9 64.1 
* Expressed as LSMEANS. 
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CHAPTER IX 
THE RESPONSE OF NEWLY ARRIVED STOCKER CATTLE TO 
DIFFERENT MEDICAL REGIMENS 
Summary 
Five hundred twenty-four newly received steer and bull calves and 
yearlings that required treatment for sickness were used in three 
different experiments to study the response of cattle treated with 
oxytetracycline (OTC) plus sulfamethazine boluses (SB}, amoxicillin, or 
potentiated sulfa boluses (PSB}. In experiment one, 173 head of 523 
received cattle became sick and were treated as follows: 28 head 
received OTC plus SB, 35 head received amoxicillin, 67 head received 
PSB, and 43 head served as negative controls (not treated for 
sickness). The percent responses to the three drug treatments were 
82.1%, 45.7%, and 91.0% for OTC plus SB, amoxicillin, and PSB, 
respectively. In experiment two, 219 head of 463 received cattle 
became sick and were treated as follows: 75 head received OTC plus SB, 
83 head received PSB, and 61 head served as negative controls. The 
percent response to the two drugs were 56.0% and 51.1% for OTC plus SB 
and PSB, respectively. The negative controls were sick for more (P<.05} 
days than either of the treated groups and death loss was much higher 
(32.8 vs 3.2% of the sick cattle}. In experiment three, 237 of 502 
cattle were treated with either OTC plus SB (107 head} or PSB (130 
head}. The responses to OTC plus SB and PSB were 59.3% and 57. 5%, 
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respectively. The percent death losses in the three experiments were 
.76%, 5.4%, and 1.8%, respectively. 
Introduction 
Between two and five percent of newly arrived stocker cattle 
received in Oklahoma die of stress related diseases, primarily the 
Bovine Respiratory Disease (BRD) complex, shortly after shipping (Gill, 
1985). Morbidity ranges from 0 to 100 percent with an average between 
25 and 30 percent. In order to prevent excessive death loss and 
decreased performance, sick cattle must respond to drug therapy. 
Studies have shown that cattle exhibiting signs of BRD respond well to 
oxytetracycline or sulfamethazine treatment (Breeze and Magonigle, 
1979; Breeze et al., 1980; Nash, 1983). The PSB used in this study was 
an experimental potentiated combination drug employing sulfadimethoxine 
and ormetoprim in a ratio of 5:1. The objective of this research was 
to study the response of sick cattle that were treated with either OTC 
plus SB or PSB. 
Experimental Procedure 
Experiment one was a study to determine the effect of mass 
medication on the health and performance of stocker cattle. The 
procedures for this experiment are given under experiment one of 
Chapter III of this manuscript (Hicks, 1985a). 
Experiment two was a study to determine the effect of respiratory 
syncytial virus vaccine or interferon on the health and performance of 
stocker cattle. The procedures for this experiment are given in 
Chapters V and VI of this manuscript (Hicks, 1985b, 1985d). 
Experiment three was a study to determine the effect of a live 
Pasteurella hemolytica vaccine on the health and performance of 
stocker cattle. The procedures for this experiment are given in 
Chapter VII of this manuscript (Hicks, 1985c). 
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Least-squares analysis of variance was performed on data for all 
response criteria within each experiment using the General Linear Model 
of the Statistical Analysis System (SAS). In experiment one, the 
initial models for weight gains, sick days, repulls, and response to 
treatment included truck, feed treatment, sick treatment, all two way 
interactions, and initial weight. In experiment two, the initial 
models included truck, ivermectin, medical treatment (interferon or RSV 
vaccine), sick treatment, all two way interactions, and initial weight. 
In experiment three, the initial models included truck, PH vaccine, 
feed treatment, sick treatment, all two way interactions, and initial 
weight. All models were reduced when sources of variation had observed 
significance levels greater than .20. 
Results and Discussion 
In experiment one, cattle treated with PSB or OTC plus SB 
responded significantly (P<.05) better than cattle treated with 
amoxicillin (Table XXXVII). Only 45.7% of the cattle treated with 
amoxicillin responded (recovered from sickness), whereas, response 
rates of 91% and 82.1% were observed in cattle treated with PSB and OTC 
plus SB, respectively. Cattle treated for sickness gained 31 to 59% 
faster than negative control cattle (.39 kg/day) with cattle receiving 
OTC plus SB having the highest weight gains (.62 kg/day). Cattle 
treated with PSB had gains similar (.59 kg/day) to those treated with 
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OTC plus SB. Negative control cattle had a greater number of sick days 
(8.4 days/head) than treated cattle with the OTC plus SB group having 
the fewest sick days (5.2 days/head). Number of repulls (cattle that 
had to be treated more than once for respiratory disease) were highest 
in the PSB cattle (20.9%). Death loss in the negative control cattle 
was 4.7% of those getting sick, versus 3.0%, 0%, and 0% of those 
becoming sick in the PSB, OTC plus SB and amoxicillin groups, 
respectively. 
In contrast to the above results, cattle in experiments two and 
three tended to respond slightly better when treated with OTC plus SB 
versus PSB. In experiment two, 56.0% of the cattle treated for BRD 
responded to OTC plus SB and 51.1% responded to PSB. The responses in 
experiment three were similar (59.3% for OTC + SB vs 57.5% for PSB). 
In these two experiments, daily gains tended to be greater for cattle 
treated with PSB. The PSB treated head gained 0.02 and 0.09 kg/head 
more than the OTC plus SB cattle in experiments one and two, 
respectively. However, these same cattle tended to require more 
treatment days to recover from sickness (Exp. 1- 8.3 vs 7.4 days/head 
and Exp. 2- 7.0 vs 6.7 days/head). Compared to experiment one, the PSB 
treated cattle had fewer repulls than the OTC plus SB cattle in both 
experiments two and three. The death loss in these two experiments was 
similar for the OTC plus SB and PSB groups. In experiment two, the 
negative control cattle had a greater (P<.05) number of sick days than 
either of the treated groups (12.2 vs 7.9 days/head) and the mortality 
rate was much greater (32.8% vs 3.2%). In this experiment there was a 
definite economic advantage with the treatment of sick cattle. The 
response to treatment in these experiments was much lower than that 
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observed in experiment one probably due to the fact that these cattle 
were less productive, sicker cattle than those in experiment one as 
evidenced by lower gains and higher morbidity. Studies done at 
Pawhuska tend to indicate that morbid, poorer performing cattle are 
less likely to respond to medical treatment. 
Under the conditions of these experiments there were no real 
differences in the response and performance of sick cattle treated with 
OTC plus SB or PSB·. Either medical regimen is useful in the treatment 
of newly arrived, stressed cattle showing symptoms of BRO. 
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TABLE XXX VI I 
EFFECT OF DIFFERENT MEDICAL REGIMENS ON DAILY GAINS, 
SICK DAYS, REPULLS AND RESPONSE TO FIRST 
TREATMENT IN SICK CATTLE 
* Daily 
* * * Mortal itya Head Gains Sick Repull s Response 
No. kg Days % % % 
Experiment 1 
OTC + SB 43 • 62 5.2 7.1 82.1 e 0.0 
Amoxi 35 • 51 6.9 14.3 45.7d 0.0 
PSB 67 • 59 6.5b 20.9 91. oe 3.0 
Controls 43 • 39 8.4 7.0c 4.7 
Experiment 2 
OTC + SB 75 • 38 7.4f 24.3 56.0 2.6 
PSB 83 • 40 a./ 18.5 51.1 3.8 
Controls 61 • 38 12.29 10.1 c 32.8 
Experiment 3 
OTC + SB 107 .27 6.4 19.4 59.3 3.7 
PSB 129 • 36 7.1 12.8 57.5 3.8 
* Expressed as LSMEANS. ~Percent of sick cattle 
a 5 day treatment period. Protocol required at least 
cMany of these cattle never recovered and remained in the sick pen the 
d entire trial 
f,eMeans with different superscripts differ (P<.Ol) 
,gMeans with different superscripts differ (P<. 05) 
CHAPTER X 
THE EFFECT OF IVERMECTIN ON HEALTH AND 
PERFORMANCE OF NEWLY ARRIVED 
STOCKER CATTLE 
S urnmary 
Eight hundred fifty-five newly received steer and bull calves and 
yearlings were used in two different experiments to determine the 
effect of ivermectin on performance and health. This study was 
superimposed across the two experiments. In experiment one, 391 head 
averaging 210 kilograms were divided into two groups. One hundred 
ninety-three received routine processing on arrival and 198 received 
routine processing plus ivermectin. Deworming with ivermectin 
increased daily gains by 28.3% (P<.001, .68 vs .53 kg/head). The 
number of sick days per head decreased slightly with ivermectin (3.5 vs 
3.8 days/head). 
In experiment two, 463 head averaging 218 kilograms were divided 
in two groups. Two hundred twenty-three received routine processing on 
arrival and 240 received routine processing plus ivermectin. 
Ivermectin treatment increased daily gains by 31.1% (P<.001, .80 vs .61 
kg/head). Ivermectin also tended to reduce the number of sick days per 
head (4.3 vs 5.0 days/head) and reduce morbidity (48.6 vs 51.3%). 
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Introduction 
The effects of anthelmintics on the performance of newly received 
stocker cattle has been variable (Davis and Caley, 1979; Hanke and 
Lindor, 1983; Winder et al., 1983). An anthelmintic is of no benefit 
if the cattle have minimal parasite burden or if resistance is present. 
The most pathogenic and economically important internal parasite of 
cattle is considered to be the abomasal nematode, Ostertagia 
ostertagi. Traditional anthelmintics have shown limited 
effectiveness against pre-type II and type II ostertagiasis (Williams 
et a 1 • , 1984 ) • 
Ivermectin has shown over 99% efficacy against inhibited larvae of 
Ostertagia ostertagi (Williams et al. 1981) and against all types 
of gastro-intestinal nematodes (Yazwinski et al., 1981; Benz, 1983). 
It has been reported to improve weight gains of feeder calves by 11 to 
21% (Holste, 1983; Ciordia et al., 1984; Lofgreen et al., 1984c). The 
objective of this research was to study the effect of ivermectin on the 
health and performance of newly arrived stocker cattle. 
Experimental Procedure 
Experiment one determined the effect of mass medication on the 
health and performance of stocker cattle. The procedures for this 
experiment are given under in Chapter III (experiment two) of this 
manuscript (Hicks, 1985a). 
Experiment two determined the effect of respiratory syncytial 
virus (RSV) vaccine or interferon on the health and performance of 
stocker cattle. The procedures for this experiment are given in 
Chapters V and VI of this manuscript (Hicks, 1985b, 1985d). 
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Least-squares analysis of variance was performed on data for all 
response criteria within each experiment using the General Linear Model 
of the Statistical Analysis System (SAS). In both experiments, the 
initial models for weight gains, sick days, morbidity, and mortality 
included trial (truck load), ivermectin, medical treatment (mass 
medication, interferon or RSV vaccine), all two way interactions, and 
initial weight. The initial models for weight gains, sick days, and 
repulls in the sick cattle included the same sources of variation with 
the addition of sick treatment. All models were reduced when sources 
of variation had observed significance levels greater than .20. 
However, ivermectin remained in all models since it was the source of 
variation being studied. 
Results and Discussion 
Effects of ivermectin on weight gains, sick days, morbidity, and 
mortality are shown in Table XXXVIII. In both experiments average 
daily gains were significantly increased by treatment with ivermectin. 
In experiment one gains were increased by 28.3% with ivermectin (.68 vs 
.53 kg/head) and in experiment two gains were increased by 31.1% (.80 
vs .61 kg/head). The average number of sick pen days per head tended 
to decrease in cattle which received ivermectin. Morbidity was high in 
both groups, but ivermectin tended to reduce it slightly. Ivermectin 
had no effect on death loss in either experiment. 
Average daily gains by the sick cattle were also significantly 
increased by ivermectin in both experiments (Table XXXIX). In 
experiment one gains were increased by 51~4% (.56 vs .37 kg/head) and 
in experiment two gains increased by 60% (.48 vs .30 kg/head). The 
TABLE XXX VII I 
EFFECT OF IVERMECTIN ON DAILY GAINS, SICK DAYS, MORBIDITY 
AND MORTALITY IN STRESSED CATTLE 
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Experiment 1 Experiment 2 
Controls Ivermectin Controls Ivermectin 
Number of head 193 
Number of head never sick 89 
Arrival weight, kg 
* Daily gain, kg 
Daily gain of * 
head never sick, kg 
Sick days * 
Morbidity, %* 
Total Mortality, % 
Mortality excluding trt 
schedule A cattle, % 
* 
207 
3.8 
53.9 
2.6 
2.6 
198 
92 
212 
.82f 
3.5 
53.5 
3.5 
3.5 
223 
113 
218 
5.0 
51.3 
5.8 
1.3 
Expressed as LSMEANS. 
a,9Means within an experiment with different superscripts differ 
d~P<.001). 
c,lMeans within an experiment with different superscripts differ 
f(P<.OS). 
e, Means within an experiment with different superscripts differ (P<.10). 
240 
131 
218 
.aob 
1.10d 
4.3 
48.6 
5.0 
0.8 
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number of sick days per head was not effected by ivermectin. Number of 
repulls was significantly decreased by ivermectin in experiment two 
(11.2% vs 24.4%) but not in experiment one. 
The average daily gains for cattle in each truck load are listed 
in Table XXXX. In three of the loads, cattle treated with ivermectin 
gained faster (P<.05) than the control cattle. Load 5 of the 
interferon experiment is the only load in which control cattle gained 
more than cattle treated with ivermectin. With some loads, cattle may 
have been dewormed prior to arrival at the station which could explain 
why certain loads (MM #1, INF #3 and INF #5) showed no favorable 
response to ivermectin. 
Under the conditions of this study, weight gains of newly arrived 
cattle were significantly increased by treatment with ivermectin over a 
28 day receiving period. Thus, this practice should be economically 
beneficial for producers if increased gains are retained and cost of 
treatment remains low. 
Number of head 
Daily gain, kg * 
* Sick days 
Repull s, % * 
* Expressed as 
a, bMeans within 
d(P<.OOl). 
c, Means within 
(P<. 05). 
TABLE XXXIX 
EFFECT OF IVERMECTIN ON DAILY GAINS, SICK 
DAYS AND REPULLS IN SICK CATTLE 
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Experiment 1 Experiment 2 
Controls Ivermectin Controls Ivermectin 
104 106 113 108 
• 37a • 56b .30a .48b 
7.1 6.9 9.6 9.1 
23.6 23.5 24.4d 11. 2c 
LSMEANS. 
an experiment with different superscripts differ 
an experiment with different superscripts differ 
124 
TABLE XXXX 
RATE OF GAIN BY TRUCK LOAD--IVERMECTIN 
Load a Origin Arrival Date Daily Gain, kgb 
Controls Ivermectin 
MM#l TN 8-12-84 .66 • 70 
INF #1 TN 8-18-84 .67c .91d 
MM #2 AL 9-28-84 .48c .83d 
INF #2 AL 10-11-84 .lOc • 79d 
MM #3 AL 11-03-84 • 70 .86 
INF #3 KY 11-14-84 1.01 1.04 
MM #4 TX 12-06-84 .24 .37 
INF #4 TX 12-20-84 .42 .55 
INF #5 OK & TX 2-15-85 .87 .82 
~M= Mass medication experiment. 
biNF= Interferon and RSV vaccine experiment. 
Daily gain expressed as LSMEANS. 
c,dMeans with different superscript differ (P<.05). 
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